| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule motor activity | KIF13B DNAH3 KIF26A DNAH14 KIF7 STARD9 KIF19 KIF14 KIF17 DNAH9 KIF1C | 2.67e-11 | 70 | 177 | 11 | GO:0003777 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | KIF13B DNAH3 MYO1E KIF26A DNAH14 KIF7 STARD9 KIF19 KIF14 KIF17 DNAH9 KIF1C | 6.11e-10 | 118 | 177 | 12 | GO:0003774 |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 5.97e-09 | 4 | 177 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 5.97e-09 | 4 | 177 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 2.96e-08 | 5 | 177 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 6.28e-08 | 13 | 177 | 5 | GO:0050656 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 2.05e-07 | 7 | 177 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | microtubule binding | KIF13B MAP9 MAP6 KIF26A TUBGCP2 MAP10 KIF7 RMDN3 STARD9 KIF19 KIF14 CEP295 KIF17 KIF1C | 6.77e-07 | 308 | 177 | 14 | GO:0008017 |
| GeneOntologyMolecularFunction | CD8 receptor binding | 7.26e-07 | 9 | 177 | 4 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 7.26e-07 | 9 | 177 | 4 | GO:0062061 | |
| GeneOntologyMolecularFunction | sulfate binding | 7.26e-07 | 9 | 177 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.20e-06 | 10 | 177 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.20e-06 | 10 | 177 | 4 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.20e-06 | 10 | 177 | 4 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.20e-06 | 10 | 177 | 4 | GO:0046977 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.79e-06 | 42 | 177 | 6 | GO:0071889 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B DNAH3 MCM8 MYO1E KIF26A ATAD5 CHD8 ATP9B CHD4 HELQ KIF7 KIF19 KIF14 KIF17 DNAH9 KIF1C | 2.09e-06 | 441 | 177 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.79e-06 | 12 | 177 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B DNAH3 MCM8 MYO1E KIF26A ATAD5 CHD8 ATP9B CHD4 HELQ DNAH14 KIF7 STARD9 KIF19 KIF14 KIF17 DNAH9 KIF1C | 9.31e-06 | 614 | 177 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 1.30e-05 | 17 | 177 | 4 | GO:0008574 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.30e-05 | 17 | 177 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B MAP9 AKAP5 MYO1E MAP6 KIF26A SPTA1 DUSP3 TUBGCP2 MAP10 KIF7 RMDN3 PTPN3 STARD9 KIF19 CLTC KIF14 CEP295 FSCN1 CROCC CDH1 RAB3A KIF17 UTRN KIF1C | 1.39e-05 | 1099 | 177 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF13B DNAH3 RNGTT MCM8 MYO1E KIF26A ATAD5 ENPP1 CHD8 ATP9B CHD4 HELQ KIF7 KIF19 MFN2 KIF14 RAB3A KIF17 DNAH9 RAB5A KIF1C | 1.80e-05 | 839 | 177 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF13B DNAH3 RNGTT MCM8 MYO1E KIF26A ATAD5 ENPP1 CHD8 ATP9B CHD4 HELQ KIF7 KIF19 MFN2 KIF14 RAB3A KIF17 DNAH9 RAB5A KIF1C | 1.84e-05 | 840 | 177 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF13B DNAH3 RNGTT MCM8 MYO1E KIF26A ATAD5 ENPP1 CHD8 ATP9B CHD4 HELQ KIF7 KIF19 MFN2 KIF14 RAB3A KIF17 DNAH9 RAB5A KIF1C | 1.84e-05 | 840 | 177 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.59e-05 | 20 | 177 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | tubulin binding | KIF13B MAP9 MAP6 KIF26A TUBGCP2 MAP10 KIF7 RMDN3 STARD9 KIF19 KIF14 CEP295 KIF17 KIF1C | 2.94e-05 | 428 | 177 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B DNAH3 MCM8 MYO1E KIF26A ATAD5 CHD8 ATP9B CHD4 HELQ KIF7 KIF19 MFN2 KIF14 RAB3A KIF17 DNAH9 RAB5A KIF1C | 6.11e-05 | 775 | 177 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | beta-catenin binding | 9.79e-05 | 120 | 177 | 7 | GO:0008013 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.77e-04 | 32 | 177 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.26e-04 | 231 | 177 | 9 | GO:0005085 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.07e-04 | 18 | 177 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 5.39e-04 | 114 | 177 | 6 | GO:0004843 | |
| GeneOntologyMolecularFunction | protein kinase binding | KIF13B AKAP5 DUSP3 RGCC NOX4 PTPN22 LYST FAM83H ARRB2 STXBP1 CLTC KIF14 IRAK3 AKAP11 TBR1 CDC5L CDH1 UTRN | 7.74e-04 | 873 | 177 | 18 | GO:0019901 |
| GeneOntologyMolecularFunction | deubiquitinase activity | 8.39e-04 | 124 | 177 | 6 | GO:0101005 | |
| GeneOntologyMolecularFunction | cadherin binding | 9.18e-04 | 339 | 177 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 9.26e-04 | 49 | 177 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | AKAP5 ADAM18 RTN4 CDH23 ITGA9 TENM2 CTNND2 FSCN1 CDH1 CDH3 UTRN CDH8 CDH9 PHLDB2 | 9.33e-04 | 599 | 177 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | kinase binding | KIF13B AKAP5 DUSP3 RGCC NOX4 PTPN22 LYST FAM83H ARRB2 STXBP1 CLTC KIF14 IRAK3 AKAP11 MYOM2 TBR1 CDC5L CDH1 UTRN | 1.00e-03 | 969 | 177 | 19 | GO:0019900 |
| GeneOntologyMolecularFunction | WD40-repeat domain binding | 1.14e-03 | 6 | 177 | 2 | GO:0071987 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 1.41e-03 | 137 | 177 | 6 | GO:0019783 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.43e-03 | 55 | 177 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | GDP-dissociation inhibitor binding | 1.59e-03 | 7 | 177 | 2 | GO:0051021 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 1.65e-03 | 192 | 177 | 7 | GO:0008234 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.74e-03 | 58 | 177 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.91e-03 | 28 | 177 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 2.11e-03 | 8 | 177 | 2 | GO:0004571 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.74e-03 | 210 | 177 | 7 | GO:0019903 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 3.21e-03 | 337 | 177 | 9 | GO:0031625 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 3.36e-03 | 10 | 177 | 2 | GO:0015924 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 4.24e-03 | 74 | 177 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.26e-03 | 37 | 177 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 4.76e-03 | 358 | 177 | 9 | GO:0044389 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.51e-03 | 127 | 177 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RALGDS PLCD4 DENND4C TIAM2 ARFGEF3 TBC1D4 HERC2 ARHGAP20 DNMBP RGL2 PREX1 | 5.67e-03 | 507 | 177 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RALGDS PLCD4 DENND4C TIAM2 ARFGEF3 TBC1D4 HERC2 ARHGAP20 DNMBP RGL2 PREX1 | 5.67e-03 | 507 | 177 | 11 | GO:0030695 |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 2.72e-08 | 5 | 179 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 2.65e-07 | 17 | 179 | 5 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 2.65e-07 | 17 | 179 | 5 | GO:0034035 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 3.74e-07 | 8 | 179 | 4 | GO:0002485 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF13B MAP9 DNAH3 MAP6 KIF26A CUL9 TUBGCP2 MAP10 LYST NSUN7 DNAH14 KIF7 FSIP2 STARD9 CEP250 KIF19 CLTC PKHD1 TTL KIF14 CEP295 CROCC KIF17 DNAH9 PHLDB2 KIF1C | 1.58e-06 | 1058 | 179 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABHD17A SEMA4D NCKAP1 SPTA1 DUSP3 RTN4 RGCC HJURP NOX4 PTPN22 BRCC3 ICE1 CHD4 MSTN TENM2 STXBP1 MFN2 KIF14 CEP295 FSCN1 CROCC RAB3A PREX1 RAB5A PHLDB2 WDR44 EPHB1 | 4.29e-06 | 1189 | 179 | 27 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | KIF13B SEMA4D AKAP5 HLA-A HLA-B NCKAP1 HLA-C MAP6 KIF26A RTN4 HLA-G MSTN TENM2 TIAM2 MFN2 TBR1 FSCN1 CROCC CDH1 PREX1 RAB5A WDR44 | 4.44e-06 | 846 | 179 | 22 | GO:0120035 |
| GeneOntologyBiologicalProcess | cell morphogenesis | KIF13B SEMA4D AKAP5 NCKAP1 MAP6 ENPP1 SPTA1 RTN4 CDH23 NOX4 TENM2 BRWD3 TIAM2 STXBP1 PKHD1 TTL MFN2 TBR1 CTNND2 DNMBP CDH1 RAB3A CDH3 CDH8 CDH9 UNC5D EPHB1 | 4.64e-06 | 1194 | 179 | 27 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | KIF13B SEMA4D AKAP5 HLA-A HLA-B NCKAP1 HLA-C MAP6 KIF26A RTN4 HLA-G MSTN TENM2 TIAM2 MFN2 TBR1 FSCN1 CROCC CDH1 PREX1 RAB5A WDR44 | 6.09e-06 | 863 | 179 | 22 | GO:0031344 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 9.20e-06 | 16 | 179 | 4 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.20e-05 | 17 | 179 | 4 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.20e-05 | 17 | 179 | 4 | GO:0002476 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.20e-05 | 17 | 179 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.53e-05 | 18 | 179 | 4 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.53e-05 | 18 | 179 | 4 | GO:0042590 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.53e-05 | 18 | 179 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 4.27e-05 | 23 | 179 | 4 | GO:0019885 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 4.27e-05 | 23 | 179 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 5.20e-05 | 9 | 179 | 3 | GO:0042270 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 6.02e-05 | 25 | 179 | 4 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 6.02e-05 | 25 | 179 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 7.19e-05 | 50 | 179 | 5 | GO:0044331 | |
| GeneOntologyBiologicalProcess | monoubiquitinated protein deubiquitination | 7.37e-05 | 10 | 179 | 3 | GO:0035520 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 7.37e-05 | 10 | 179 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | sulfation | 8.23e-05 | 27 | 179 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 9.53e-05 | 53 | 179 | 5 | GO:0016339 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 9.54e-05 | 28 | 179 | 4 | GO:0032253 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF13B DNAH3 MAP6 KIF26A NSUN7 DNAH14 KIF7 FSIP2 STARD9 KIF19 KIF14 KIF17 DNAH9 KIF1C | 1.07e-04 | 493 | 179 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | neuron projection development | KIF13B SEMA4D AKAP5 HLA-A HLA-B NCKAP1 HLA-C MAP6 KIF26A ENPP1 RTN4 HLA-G CDH23 TENM2 TIAM2 STXBP1 TTL MFN2 TBR1 CTNND2 CDH1 RAB3A PREX1 UNC5D EPHB1 | 1.27e-04 | 1285 | 179 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 1.33e-04 | 12 | 179 | 3 | GO:0099011 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | MAP9 ATAD5 RGCC HLA-G DACH1 CUL9 BRCC3 ACTL6A WDR76 MAP10 CEP250 CLTC PKHD1 KIF14 CEP295 CDC5L PCID2 USP47 ANAPC4 | 1.44e-04 | 845 | 179 | 19 | GO:0010564 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.63e-04 | 32 | 179 | 4 | GO:0019883 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | SEMA4D RTN4 DENND4C TIAM2 ARFGEF3 MFN2 KIF14 ARHGAP20 DNMBP RGL2 PREX1 | 1.64e-04 | 333 | 179 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SEMA4D RC3H2 ZAN HLA-A SPTA1 DUSP3 RGCC HLA-G CDH23 PTPN22 ACTL6A ITGA9 TENM2 ADIPOQ STXBP1 PKHD1 CTNND2 CDH1 CDH3 CDH8 CDH9 UNC5D | 1.69e-04 | 1077 | 179 | 22 | GO:0098609 |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.72e-04 | 13 | 179 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 2.08e-04 | 34 | 179 | 4 | GO:0032252 | |
| GeneOntologyBiologicalProcess | post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery | 2.23e-04 | 3 | 179 | 2 | GO:0000973 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | MAP9 ATAD5 DUSP3 RGCC HLA-G DACH1 CUL9 BRCC3 ACTL6A WDR76 MAP10 PTPN3 CEP250 CLTC PKHD1 TTL MASTL MFN2 KIF14 CEP295 CDC5L PCID2 USP47 ANAPC4 | 2.29e-04 | 1256 | 179 | 24 | GO:0051726 |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 2.45e-04 | 142 | 179 | 7 | GO:0018958 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | SEMA4D RALGDS NCKAP1 RTN4 PLCD4 DENND4C TIAM2 ARFGEF3 MFN2 KIF14 ARHGAP20 DNMBP RGL2 PREX1 | 2.64e-04 | 538 | 179 | 14 | GO:0007264 |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 2.71e-04 | 15 | 179 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | KIF13B SEMA4D AKAP5 MAP6 RTN4 CDH23 TENM2 TIAM2 STXBP1 TTL MFN2 TBR1 CTNND2 CDH1 RAB3A UNC5D EPHB1 | 2.89e-04 | 748 | 179 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | KIF13B SEMA4D AKAP5 HLA-A HLA-B HLA-C MAP6 KIF26A RTN4 HLA-G TIAM2 MFN2 TBR1 CDH1 PREX1 | 3.02e-04 | 612 | 179 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron development | KIF13B SEMA4D AKAP5 RPGRIP1L HLA-A HLA-B NCKAP1 HLA-C MAP6 KIF26A ENPP1 RTN4 HLA-G CDH23 TENM2 TIAM2 STXBP1 TTL MFN2 TBR1 CTNND2 CDH1 RAB3A PREX1 UNC5D EPHB1 | 3.82e-04 | 1463 | 179 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.93e-04 | 40 | 179 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.32e-04 | 41 | 179 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 4.32e-04 | 41 | 179 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | negative regulation of skeletal muscle satellite cell proliferation | 4.44e-04 | 4 | 179 | 2 | GO:1902723 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 4.62e-04 | 74 | 179 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 4.62e-04 | 74 | 179 | 5 | GO:0006584 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 4.75e-04 | 42 | 179 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 4.83e-04 | 114 | 179 | 6 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | ABHD17A HLA-A HLA-B HLA-C SPTA1 RTN4 HLA-G ARRB2 TBC1D4 ADIPOQ STXBP1 MFN2 KIF14 IRAK3 CDH1 PCID2 PHLDB2 WDR44 | 5.40e-04 | 864 | 179 | 18 | GO:0051129 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP9 MAP6 CUL9 TUBGCP2 MAP10 FSIP2 STARD9 CEP250 KIF19 CLTC PKHD1 TTL KIF14 CEP295 CROCC PHLDB2 | 5.58e-04 | 720 | 179 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | SEMA4D NCKAP1 RGCC NOX4 PTPN22 BRCC3 ICE1 MSTN TENM2 CEP295 FSCN1 CROCC PHLDB2 EPHB1 | 5.77e-04 | 582 | 179 | 14 | GO:0044089 |
| GeneOntologyBiologicalProcess | blastocyst formation | 5.89e-04 | 78 | 179 | 5 | GO:0001825 | |
| GeneOntologyBiologicalProcess | ERAD pathway | 6.06e-04 | 119 | 179 | 6 | GO:0036503 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 6.19e-04 | 45 | 179 | 4 | GO:0017158 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | KIF13B SEMA4D AKAP5 NCKAP1 MAP6 RTN4 TENM2 TIAM2 STXBP1 TTL MFN2 TBR1 CTNND2 CDH1 RAB3A UNC5D EPHB1 | 6.38e-04 | 802 | 179 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 6.62e-04 | 121 | 179 | 6 | GO:0006576 | |
| GeneOntologyBiologicalProcess | protein catabolic process | ABHD17A RC3H2 MAN1A1 UGGT1 MKRN2 CASP8 CUL9 OAZ1 UBE4A EDEM3 PTPN3 ARRB2 BBS7 KIF14 IRAK3 UBXN2A HERC2 TOPORS CDH1 EIF2AK3 ANAPC4 | 6.96e-04 | 1115 | 179 | 21 | GO:0030163 |
| GeneOntologyBiologicalProcess | cell cycle process | MAP9 ATAD5 RGCC HJURP HLA-G DACH1 CUL9 BRCC3 ACTL6A TUBGCP2 WDR76 MAP10 STARD9 CEP250 CLTC PKHD1 TTL MASTL KIF14 CEP295 CDC5L CROCC PCID2 USP47 ANAPC4 | 7.08e-04 | 1441 | 179 | 25 | GO:0022402 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 7.31e-04 | 47 | 179 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 7.31e-04 | 47 | 179 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | RC3H2 MAN1A1 UGGT1 MKRN2 CASP8 CUL9 OAZ1 UBE4A EDEM3 ARRB2 BBS7 KIF14 UBXN2A HERC2 TOPORS EIF2AK3 ANAPC4 | 7.32e-04 | 812 | 179 | 17 | GO:0051603 |
| GeneOntologyBiologicalProcess | negative regulation of skeletal muscle cell proliferation | 7.36e-04 | 5 | 179 | 2 | GO:0014859 | |
| GeneOntologyBiologicalProcess | positive regulation of CD8-positive, alpha-beta T cell proliferation | 7.36e-04 | 5 | 179 | 2 | GO:2000566 | |
| GeneOntologyBiologicalProcess | negative regulation of satellite cell differentiation | 7.36e-04 | 5 | 179 | 2 | GO:1902725 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 7.40e-04 | 82 | 179 | 5 | GO:0017156 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 7.85e-04 | 125 | 179 | 6 | GO:0016579 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 7.92e-04 | 48 | 179 | 4 | GO:0002478 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | KIF13B SEMA4D AKAP5 NCKAP1 MAP6 RTN4 TENM2 TIAM2 STXBP1 TTL MFN2 TBR1 CTNND2 CDH1 RAB3A UNC5D EPHB1 | 8.04e-04 | 819 | 179 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | KIF13B SEMA4D AKAP5 NCKAP1 MAP6 RTN4 TENM2 TIAM2 STXBP1 TTL MFN2 TBR1 CTNND2 CDH1 RAB3A UNC5D EPHB1 | 8.83e-04 | 826 | 179 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of tolerance induction | 1.00e-03 | 23 | 179 | 3 | GO:0002643 | |
| GeneOntologyCellularComponent | microtubule | KIF13B MAP9 DNAH3 RPGRIP1L MAP6 KIF26A TUBGCP2 MAP10 DNAH14 KIF7 CEP170 RMDN3 KIF19 CLTC TTL KIF14 CEP295 KIF17 DNAH9 WDR44 KIF1C | 6.53e-09 | 533 | 179 | 21 | GO:0005874 |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.78e-07 | 7 | 179 | 4 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.05e-06 | 10 | 179 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF13B MAP9 DNAH3 RPGRIP1L NCKAP1 MAP6 KIF26A TUBGCP2 MAP10 DNAH14 FAM83H KIF7 CEP170 RMDN3 KIF19 CLTC TTL KIF14 CEP295 KIF17 DNAH9 WDR44 KIF1C | 2.78e-06 | 899 | 179 | 23 | GO:0099513 |
| GeneOntologyCellularComponent | kinesin complex | 3.73e-06 | 49 | 179 | 6 | GO:0005871 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 4.87e-06 | 14 | 179 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | catenin complex | 7.27e-06 | 32 | 179 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B MAP9 DNAH3 MTMR12 RPGRIP1L NCKAP1 MAP6 KIF26A TUBGCP2 MAP10 DNAH14 FAM83H KIF7 CEP170 ADAMTS10 RMDN3 KIF19 CLTC TTL KIF14 CEP295 MYOM2 KIF17 DNAH9 WDR44 KIF1C | 8.76e-06 | 1179 | 179 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B MAP9 DNAH3 MTMR12 RPGRIP1L NCKAP1 MAP6 KIF26A TUBGCP2 MAP10 DNAH14 FAM83H KIF7 CEP170 ADAMTS10 RMDN3 KIF19 CLTC TTL KIF14 CEP295 MYOM2 KIF17 DNAH9 WDR44 KIF1C | 9.86e-06 | 1187 | 179 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.06e-05 | 161 | 179 | 9 | GO:0005875 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.13e-05 | 17 | 179 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC14 RPGRIP1L RGCC CCDC18 CDH23 CHD4 TUBGCP2 MAP10 LUZP1 KIF7 CEP170 BBS7 STARD9 CEP250 PKHD1 MASTL AKAP11 CEP295 HERC2 CROCC TOPORS KIF17 | 1.32e-05 | 919 | 179 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | actin-based cell projection | KIF13B AKAP5 MYO1E HLA-G CDH23 TENM2 TIAM2 FSCN1 CDH1 UTRN EPHB1 | 2.91e-05 | 278 | 179 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | Golgi medial cisterna | 4.05e-05 | 23 | 179 | 4 | GO:0005797 | |
| GeneOntologyCellularComponent | transport vesicle membrane | BTBD8 HLA-A HLA-B HLA-C MAP6 HLA-G ARFGEF3 CLTC UNC13C RAB3A RAB5A | 4.69e-05 | 293 | 179 | 11 | GO:0030658 |
| GeneOntologyCellularComponent | MHC protein complex | 6.71e-05 | 26 | 179 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 7.93e-05 | 83 | 179 | 6 | GO:0030670 | |
| GeneOntologyCellularComponent | cis-Golgi network | 9.05e-05 | 85 | 179 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | filopodium | 9.25e-05 | 123 | 179 | 7 | GO:0030175 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.70e-04 | 230 | 179 | 9 | GO:0019898 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.81e-04 | 137 | 179 | 7 | GO:0019897 | |
| GeneOntologyCellularComponent | spindle | MAP9 BRCC3 TUBGCP2 MAP10 CEP170 RMDN3 CEP250 CLTC PKHD1 TTL KIF14 CEP295 TOPORS | 2.19e-04 | 471 | 179 | 13 | GO:0005819 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.21e-04 | 35 | 179 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | centrosome | CCDC14 RPGRIP1L RGCC CCDC18 CDH23 CHD4 TUBGCP2 MAP10 LUZP1 CEP170 BBS7 CEP250 PKHD1 MASTL AKAP11 CEP295 CROCC | 3.46e-04 | 770 | 179 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | phagocytic vesicle | 4.16e-04 | 157 | 179 | 7 | GO:0045335 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 4.51e-04 | 42 | 179 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | endocytic vesicle | BTBD8 HLA-A HLA-B MYO1E HLA-C HLA-G ARRB2 STXBP1 CLTC DMBT1 RAB5A | 4.93e-04 | 384 | 179 | 11 | GO:0030139 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.97e-04 | 212 | 179 | 8 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 5.46e-04 | 215 | 179 | 8 | GO:0030662 | |
| GeneOntologyCellularComponent | axon | KIF13B MAP9 BTBD8 MAP6 SPTA1 TENM2 TIAM2 STXBP1 UNC13C FSCN1 CDH1 RAB3A PREX1 RAB5A CDH8 CDH9 KIF1C EPHB1 | 6.62e-04 | 891 | 179 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | recycling endosome | 6.73e-04 | 222 | 179 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | centriole | 7.17e-04 | 172 | 179 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | filopodium membrane | 7.33e-04 | 21 | 179 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 7.54e-04 | 48 | 179 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | spindle microtubule | 8.66e-04 | 86 | 179 | 5 | GO:0005876 | |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 1.07e-03 | 6 | 179 | 2 | GO:0098944 | |
| GeneOntologyCellularComponent | cytoplasmic region | DNAH3 RPGRIP1L STXBP1 BBS7 KIF19 UNC13C KIF17 DNAH9 PHLDB2 KIF1C | 1.12e-03 | 360 | 179 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane protein complex | BTBD8 HLA-A HLA-B HLA-C HLA-G CDH23 CASP8 NOX4 ITGA9 CLTC CACNA1I CDH1 CDH3 UTRN CDH8 CDH9 | 1.21e-03 | 785 | 179 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | postsynaptic endosome | 1.39e-03 | 26 | 179 | 3 | GO:0098845 | |
| GeneOntologyCellularComponent | ciliary basal body | 1.49e-03 | 195 | 179 | 7 | GO:0036064 | |
| GeneOntologyCellularComponent | non-motile cilium | 1.53e-03 | 196 | 179 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | 90S preribosome | 1.92e-03 | 29 | 179 | 3 | GO:0030686 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 2.07e-03 | 153 | 179 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 2.21e-03 | 64 | 179 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.79e-03 | 112 | 179 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP5 MAP6 NOX4 PTPN22 ATP9B ITPR3 TG STXBP1 CEP250 PKHD1 CDC5L CDH1 RAB3A EIF2AK3 PREX1 RAB5A WDR44 | 2.82e-03 | 934 | 179 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | dendrite | ABHD17A AKAP5 MAP6 ENPP1 TENM2 ITPR3 ARRB2 UBXN2A CTNND2 FSCN1 KIF17 PREX1 RAB5A CDH9 KIF1C EPHB1 | 2.95e-03 | 858 | 179 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ABHD17A AKAP5 MAP6 ENPP1 TENM2 ITPR3 ARRB2 UBXN2A CTNND2 FSCN1 KIF17 PREX1 RAB5A CDH9 KIF1C EPHB1 | 3.02e-03 | 860 | 179 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 3.75e-03 | 230 | 179 | 7 | GO:0098562 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 3.81e-03 | 11 | 179 | 2 | GO:0098843 | |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 3.81e-03 | 11 | 179 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | coated vesicle | 3.95e-03 | 360 | 179 | 9 | GO:0030135 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 4.47e-03 | 125 | 179 | 5 | GO:0140534 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 4.53e-03 | 78 | 179 | 4 | GO:0001917 | |
| GeneOntologyCellularComponent | synaptic membrane | ABHD17A AKAP5 RTN4 TENM2 ARRB2 STXBP1 CLTC UNC13C UTRN RAB5A CDH8 CDH9 | 4.53e-03 | 583 | 179 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | spindle midzone | 4.83e-03 | 40 | 179 | 3 | GO:0051233 | |
| GeneOntologyCellularComponent | transport vesicle | BTBD8 HLA-A HLA-B HLA-C MAP6 HLA-G ARFGEF3 CLTC UNC13C RAB3A RAB5A | 5.24e-03 | 519 | 179 | 11 | GO:0030133 |
| GeneOntologyCellularComponent | postsynaptic recycling endosome | 5.35e-03 | 13 | 179 | 2 | GO:0098837 | |
| GeneOntologyCellularComponent | cuticular plate | 5.35e-03 | 13 | 179 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | mitotic spindle microtubule | 6.20e-03 | 14 | 179 | 2 | GO:1990498 | |
| MousePheno | spinal cord inflammation | 9.58e-07 | 8 | 154 | 4 | MP:0030987 | |
| MousePheno | abnormal gallbladder morphology | 4.07e-06 | 60 | 154 | 7 | MP:0005084 | |
| MousePheno | abnormal biliary tract morphology | RPGRIP1L SPTA1 FREM1 FAM83H SULT1A2 SULT1A4 SULT1A1 SULT1A3 PKHD1 | 5.67e-06 | 117 | 154 | 9 | MP:0005083 |
| Domain | - | 7.04e-09 | 44 | 176 | 8 | 3.40.850.10 | |
| Domain | Kinesin | 7.04e-09 | 44 | 176 | 8 | PF00225 | |
| Domain | KISc | 7.04e-09 | 44 | 176 | 8 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 7.04e-09 | 44 | 176 | 8 | PS00411 | |
| Domain | Kinesin_motor_dom | 7.04e-09 | 44 | 176 | 8 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 7.04e-09 | 44 | 176 | 8 | PS50067 | |
| Domain | Kinesin_motor_CS | 1.00e-07 | 41 | 176 | 7 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.42e-07 | 43 | 176 | 7 | IPR027640 | |
| Domain | P-loop_NTPase | KIF13B DNAH3 SAMD9 MCM8 MYO1E KIF26A ATAD5 CHD8 CHD4 HELQ DNAH14 KIF7 SULT1A2 GTPBP8 SULT1A1 STARD9 KIF19 MFN2 KIF14 CAMTA1 RAB3A KIF17 DNAH9 RAB5A KIF1C | 4.09e-07 | 848 | 176 | 25 | IPR027417 |
| Domain | FHA | 5.79e-06 | 28 | 176 | 5 | SM00240 | |
| Domain | FHA | 9.78e-06 | 31 | 176 | 5 | PF00498 | |
| Domain | Kinesin_assoc | 1.61e-05 | 6 | 176 | 3 | PF16183 | |
| Domain | MHC_I_a_C | 1.61e-05 | 6 | 176 | 3 | IPR010579 | |
| Domain | Kinesin_assoc | 1.61e-05 | 6 | 176 | 3 | IPR032405 | |
| Domain | MHC_I_C | 1.61e-05 | 6 | 176 | 3 | PF06623 | |
| Domain | - | SEMA4D WDR76 LYST BRWD3 DMXL1 PWP1 NBAS PPP2R2B DCAF8L1 TULP4 BBS7 ANAPC4 WDR44 | 1.70e-05 | 333 | 176 | 13 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | SEMA4D WDR76 LYST BRWD3 DMXL1 PWP1 NBAS PPP2R2B DCAF8L1 TULP4 BBS7 ANAPC4 WDR44 | 1.82e-05 | 335 | 176 | 13 | IPR015943 |
| Domain | - | 2.09e-05 | 36 | 176 | 5 | 2.60.200.20 | |
| Domain | FHA_dom | 2.09e-05 | 36 | 176 | 5 | IPR000253 | |
| Domain | MHC_I | 4.02e-05 | 21 | 176 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 4.02e-05 | 21 | 176 | 4 | IPR001039 | |
| Domain | Quino_amine_DH_bsu | 4.88e-05 | 22 | 176 | 4 | IPR011044 | |
| Domain | WD_REPEATS_1 | WDR76 LYST BRWD3 DMXL1 PWP1 NBAS PPP2R2B DCAF8L1 TULP4 HERC2 WDR44 | 6.82e-05 | 278 | 176 | 11 | PS00678 |
| Domain | - | 6.99e-05 | 24 | 176 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 6.99e-05 | 24 | 176 | 4 | IPR011161 | |
| Domain | WD_REPEATS_2 | WDR76 LYST BRWD3 DMXL1 PWP1 NBAS PPP2R2B DCAF8L1 TULP4 HERC2 WDR44 | 7.04e-05 | 279 | 176 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | WDR76 LYST BRWD3 DMXL1 PWP1 NBAS PPP2R2B DCAF8L1 TULP4 HERC2 WDR44 | 7.04e-05 | 279 | 176 | 11 | PS50294 |
| Domain | Cadherin_C | 8.26e-05 | 25 | 176 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 8.26e-05 | 25 | 176 | 4 | IPR000233 | |
| Domain | WD40_repeat_dom | WDR76 LYST BRWD3 DMXL1 PWP1 PPP2R2B DCAF8L1 TULP4 BBS7 ANAPC4 WDR44 | 1.23e-04 | 297 | 176 | 11 | IPR017986 |
| Domain | SMAD_FHA_domain | 1.27e-04 | 52 | 176 | 5 | IPR008984 | |
| Domain | Catenin_binding_dom | 1.51e-04 | 29 | 176 | 4 | IPR027397 | |
| Domain | - | 1.51e-04 | 29 | 176 | 4 | 4.10.900.10 | |
| Domain | FHA_DOMAIN | 1.97e-04 | 31 | 176 | 4 | PS50006 | |
| Domain | Cul7 | 2.63e-04 | 3 | 176 | 2 | PF11515 | |
| Domain | CPH_domain | 2.63e-04 | 3 | 176 | 2 | IPR021097 | |
| Domain | WD40_repeat | WDR76 LYST BRWD3 DMXL1 PWP1 PPP2R2B DCAF8L1 TULP4 HERC2 WDR44 | 2.65e-04 | 272 | 176 | 10 | IPR001680 |
| Domain | Dynein_heavy_chain_D4_dom | 2.77e-04 | 14 | 176 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.77e-04 | 14 | 176 | 3 | IPR024743 | |
| Domain | MT | 2.77e-04 | 14 | 176 | 3 | PF12777 | |
| Domain | AAA_8 | 2.77e-04 | 14 | 176 | 3 | PF12780 | |
| Domain | DHC_fam | 3.44e-04 | 15 | 176 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.44e-04 | 15 | 176 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.44e-04 | 15 | 176 | 3 | IPR004273 | |
| Domain | Sulfotransfer_1 | 3.55e-04 | 36 | 176 | 4 | PF00685 | |
| Domain | Sulfotransferase_dom | 3.55e-04 | 36 | 176 | 4 | IPR000863 | |
| Domain | MHC_I/II-like_Ag-recog | 4.38e-04 | 38 | 176 | 4 | IPR011162 | |
| Domain | Ubiquitin_3 | 5.23e-04 | 4 | 176 | 2 | PF14836 | |
| Domain | Ub_USP-typ | 5.23e-04 | 4 | 176 | 2 | IPR028135 | |
| Domain | WD40 | 8.02e-04 | 259 | 176 | 9 | PF00400 | |
| Domain | Cadherin | 8.86e-04 | 118 | 176 | 6 | IPR002126 | |
| Domain | WD40 | 1.02e-03 | 268 | 176 | 9 | SM00320 | |
| Domain | DUSP | 1.29e-03 | 6 | 176 | 2 | PF06337 | |
| Domain | DUSP | 1.29e-03 | 6 | 176 | 2 | SM00695 | |
| Domain | TYR_PHOSPHATASE_1 | 1.32e-03 | 86 | 176 | 5 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.39e-03 | 87 | 176 | 5 | PS50056 | |
| Domain | C1-set | 1.67e-03 | 54 | 176 | 4 | PF07654 | |
| Domain | APC_su10/DOC_dom | 1.80e-03 | 7 | 176 | 2 | IPR004939 | |
| Domain | Glyco_hydro_47 | 1.80e-03 | 7 | 176 | 2 | PF01532 | |
| Domain | DOC | 1.80e-03 | 7 | 176 | 2 | PS51284 | |
| Domain | DUSP | 1.80e-03 | 7 | 176 | 2 | PS51283 | |
| Domain | ANAPC10 | 1.80e-03 | 7 | 176 | 2 | PF03256 | |
| Domain | - | 1.80e-03 | 7 | 176 | 2 | 3.30.2230.10 | |
| Domain | - | 1.80e-03 | 7 | 176 | 2 | 1.50.10.50 | |
| Domain | Pept_C19_DUSP | 1.80e-03 | 7 | 176 | 2 | IPR006615 | |
| Domain | APC10 | 1.80e-03 | 7 | 176 | 2 | SM01337 | |
| Domain | Ubiquitin-rel_dom | 1.83e-03 | 184 | 176 | 7 | IPR029071 | |
| Domain | - | DNAH3 SAMD9 MCM8 MYO1E ATAD5 CHD8 CHD4 HELQ DNAH14 SULT1A2 GTPBP8 SULT1A1 MFN2 RAB3A DNAH9 RAB5A | 1.89e-03 | 746 | 176 | 16 | 3.40.50.300 |
| Domain | IGc1 | 1.91e-03 | 56 | 176 | 4 | SM00407 | |
| Domain | Ig/MHC_CS | 2.18e-03 | 58 | 176 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 2.18e-03 | 58 | 176 | 4 | IPR003597 | |
| Domain | Cadherin_pro | 2.38e-03 | 8 | 176 | 2 | SM01055 | |
| Domain | Cadherin_pro_dom | 2.38e-03 | 8 | 176 | 2 | IPR014868 | |
| Domain | Glyco_hydro_47 | 2.38e-03 | 8 | 176 | 2 | IPR001382 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.46e-03 | 99 | 176 | 5 | IPR029021 | |
| Domain | IG_MHC | 2.46e-03 | 60 | 176 | 4 | PS00290 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 3.65e-08 | 5 | 132 | 4 | M47807 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.09e-07 | 6 | 132 | 4 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.52e-07 | 7 | 132 | 4 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.52e-07 | 7 | 132 | 4 | M47530 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 8.92e-07 | 9 | 132 | 4 | MM14527 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 2.30e-06 | 11 | 132 | 4 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.43e-06 | 12 | 132 | 4 | M47529 | |
| Pathway | KEGG_SULFUR_METABOLISM | 4.92e-06 | 13 | 132 | 4 | M18256 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 2.03e-05 | 18 | 132 | 4 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 3.17e-05 | 20 | 132 | 4 | MM1374 | |
| Pathway | WP_ESTROGEN_METABOLISM | 4.71e-05 | 22 | 132 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 5.67e-05 | 23 | 132 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 6.75e-05 | 24 | 132 | 4 | M16289 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 7.98e-05 | 25 | 132 | 4 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 7.98e-05 | 25 | 132 | 4 | MM1465 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.22e-04 | 52 | 132 | 5 | M13103 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.45e-04 | 29 | 132 | 4 | M1062 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 2.52e-04 | 133 | 132 | 7 | M16476 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 3.82e-04 | 37 | 132 | 4 | M18615 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.69e-04 | 39 | 132 | 4 | MM15695 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 4.96e-04 | 17 | 132 | 3 | M39483 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.96e-04 | 70 | 132 | 5 | M12294 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 5.69e-04 | 41 | 132 | 4 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 6.83e-04 | 43 | 132 | 4 | M12617 | |
| Pathway | WP_RETINOL_METABOLISM | 7.46e-04 | 44 | 132 | 4 | MM15851 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 7.69e-04 | 116 | 132 | 6 | MM15715 | |
| Pubmed | CCDC14 RELCH MTMR12 AKAP5 RPGRIP1L RNGTT HLA-A HLA-C ATAD5 UGGT1 CCDC18 NUP98 KRI1 PTPN22 BRCC3 LUZP1 ESF1 KIF7 ITPR3 PTPN3 TBC1D4 CLTC KIF14 HERC2 CDC5L USP1 UTRN KDM6A | 1.19e-12 | 1049 | 180 | 28 | 27880917 | |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 1.50e-11 | 37 | 180 | 8 | 11416179 | |
| Pubmed | Mapping of 12 markers in the proximal region of mouse chromosome 17 using recombinant t haplotypes. | 8.51e-11 | 15 | 180 | 6 | 7749235 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B MTMR12 NCKAP1 HJURP CCDC18 BRCC3 LYST DENND4C LUZP1 FAM83H CEP170 ARFGEF3 FSIP2 PTPN3 TBC1D4 STARD9 KIF14 AKAP11 DNMBP RGL2 UTRN PHLDB2 KIF1C | 1.44e-10 | 861 | 180 | 23 | 36931259 |
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 11861287 | ||
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 33414449 | ||
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 8943792 | ||
| Pubmed | Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. | 6.94e-10 | 4 | 180 | 4 | 18782112 | |
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 8288252 | ||
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 25370010 | ||
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 24318996 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 6.94e-10 | 4 | 180 | 4 | 12390022 | |
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 8424956 | ||
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 19762282 | ||
| Pubmed | 6.94e-10 | 4 | 180 | 4 | 16459714 | ||
| Pubmed | RC3H2 RPGRIP1L CCDC18 TUBGCP2 KIF7 ARFGEF3 NBAS KIF14 AKAP11 DNMBP PHLDB2 USP47 KIF1C | 7.79e-10 | 251 | 180 | 13 | 29778605 | |
| Pubmed | Genetic mapping of 10 microsatellites in the t complex region of mouse chromosome 17. | 8.67e-10 | 10 | 180 | 5 | 9585437 | |
| Pubmed | 8.67e-10 | 10 | 180 | 5 | 6096010 | ||
| Pubmed | Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. | 8.67e-10 | 10 | 180 | 5 | 2357966 | |
| Pubmed | 1.58e-09 | 11 | 180 | 5 | 1676981 | ||
| Pubmed | Polymorphism and linkage of the alpha A-crystallin gene in t-haplotypes of the mouse. | 1.58e-09 | 11 | 180 | 5 | 3036643 | |
| Pubmed | 1.58e-09 | 11 | 180 | 5 | 2911572 | ||
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 2.88e-09 | 25 | 180 | 6 | 9275178 | |
| Pubmed | The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. | 3.46e-09 | 5 | 180 | 4 | 19728333 | |
| Pubmed | 3.46e-09 | 5 | 180 | 4 | 25053625 | ||
| Pubmed | 3.46e-09 | 5 | 180 | 4 | 27522114 | ||
| Pubmed | 3.46e-09 | 5 | 180 | 4 | 24802129 | ||
| Pubmed | 3.46e-09 | 5 | 180 | 4 | 11389699 | ||
| Pubmed | 3.46e-09 | 5 | 180 | 4 | 29908303 | ||
| Pubmed | Meiotic mapping of murine chromosome 17: the string of loci around l(17)-2Pas. | 4.37e-09 | 13 | 180 | 5 | 1794044 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SAMD9 COL17A1 MYO1E HLA-C UGGT1 MKRN2 NUP98 KRI1 ACTL6A TUBGCP2 LUZP1 ESF1 FAM83H ITPR3 PWP1 CEP170 PTPN3 CLTC KIF14 UTP20 CDC5L FSCN1 TOPORS CDH1 PHLDB2 | 8.98e-09 | 1257 | 180 | 25 | 36526897 |
| Pubmed | HLA-A HLA-B NCKAP1 HLA-C HLA-G CUL9 ITPR3 IGFBP3 TULP4 CLTC HERC2 DNMBP CDH1 EIF2AK3 | 1.00e-08 | 371 | 180 | 14 | 15747579 | |
| Pubmed | 1.01e-08 | 15 | 180 | 5 | 1350556 | ||
| Pubmed | NCKAP1 UGGT1 NUP98 KRI1 CUL9 CHD8 CHD4 ESF1 ITPR3 PWP1 CEP170 CLTC KIF14 UTP20 HERC2 FSCN1 UTRN USP47 | 1.01e-08 | 653 | 180 | 18 | 22586326 | |
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 11932387 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 8671651 | ||
| Pubmed | The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. | 1.03e-08 | 6 | 180 | 4 | 10366557 | |
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 10799863 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 14595379 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 9373217 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 19555986 | ||
| Pubmed | A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. | 1.03e-08 | 6 | 180 | 4 | 2789433 | |
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 22503975 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 8612235 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 10982373 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 9582271 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 10546855 | ||
| Pubmed | HIV immune evasion disruption of antigen presentation by the HIV Nef protein. | 1.03e-08 | 6 | 180 | 4 | 21762823 | |
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 9120272 | ||
| Pubmed | 1.03e-08 | 6 | 180 | 4 | 9840288 | ||
| Pubmed | Spatial and functional relationship of GGAs and AP-1 in Drosophila and HeLa cells. | 1.03e-08 | 6 | 180 | 4 | 19847956 | |
| Pubmed | Repression of MHC class I gene promoter activity by two-exon Tat of HIV. | 1.03e-08 | 6 | 180 | 4 | 8493575 | |
| Pubmed | Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. | 1.03e-08 | 6 | 180 | 4 | 8877415 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RNGTT NUP98 CHD8 CHD4 ACTL6A ESF1 ITPR3 PWP1 CEP170 CLTC HERC2 USP15 CDH1 EIF2AK3 ANAPC4 | 1.14e-08 | 440 | 180 | 15 | 34244565 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC14 MIS18BP1 RPGRIP1L NCKAP1 BMP2K KRI1 CASP8 TUBGCP2 LUZP1 FAM83H KIF7 CEP250 KIF14 CEP295 HERC2 DNMBP USP15 PCID2 USP47 KIF1C | 2.19e-08 | 853 | 180 | 20 | 28718761 |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 2808323 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 2.40e-08 | 7 | 180 | 4 | 12459592 | |
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 2.40e-08 | 7 | 180 | 4 | 28234229 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 2642506 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 9037062 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 19643141 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 20957233 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 11580250 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 2.40e-08 | 7 | 180 | 4 | 20974936 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 10704462 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 2.40e-08 | 7 | 180 | 4 | 2908875 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 3458188 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 19462379 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 2.40e-08 | 7 | 180 | 4 | 6300850 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 2.40e-08 | 7 | 180 | 4 | 6265910 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 2.40e-08 | 7 | 180 | 4 | 2906539 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 3013627 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 3894562 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 2.40e-08 | 7 | 180 | 4 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 2.40e-08 | 7 | 180 | 4 | 18383043 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 8833240 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 21178009 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 2.40e-08 | 7 | 180 | 4 | 3025084 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 2.40e-08 | 7 | 180 | 4 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 2.40e-08 | 7 | 180 | 4 | 6786753 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 6583704 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 6571712 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 12006653 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 7520098 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 18057255 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 10452993 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 1316930 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 26714929 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 6280871 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 10799615 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 10993729 | ||
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 2.40e-08 | 7 | 180 | 4 | 19454713 | |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 10229092 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 2879284 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 7306483 | ||
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 2351932 | ||
| Interaction | NINL interactions | CCDC14 PRR4 MIS18BP1 RPGRIP1L BMP2K TUBGCP2 LUZP1 FAM83H KIF7 CEP170 ARRB2 TBC1D4 CEP250 CLTC KIF14 CEP295 DMBT1 DNMBP | 1.37e-07 | 458 | 178 | 18 | int:NINL |
| Interaction | YWHAQ interactions | KIF13B MTMR12 RPGRIP1L NCKAP1 SPTA1 HJURP CCDC18 WDR76 LYST DENND4C LUZP1 FAM83H CEP170 RMDN3 PTPN3 ARRB2 TBC1D4 STARD9 CEP250 CLTC KIF14 AKAP11 CDC5L FSCN1 DNMBP RGL2 PHLDB2 USP47 KIF1C | 1.68e-07 | 1118 | 178 | 29 | int:YWHAQ |
| Interaction | KRT18 interactions | CCDC14 RPGRIP1L COL17A1 CCDC18 CASP8 CHD4 WDR76 FAM83H KIF7 ITPR3 BBS7 CLTC KIF14 IRAK3 USP4 CDC5L CDH1 | 1.99e-07 | 419 | 178 | 17 | int:KRT18 |
| Interaction | YWHAB interactions | KIF13B RC3H2 MTMR12 NCKAP1 HJURP CCDC18 WDR76 LYST DENND4C LUZP1 FAM83H CEP170 RMDN3 PTPN3 ARRB2 TBC1D4 STARD9 CLTC KIF14 AKAP11 USP4 DNMBP CDH1 RGL2 PHLDB2 USP47 KIF1C | 2.84e-07 | 1014 | 178 | 27 | int:YWHAB |
| Interaction | YWHAH interactions | KIF13B MTMR12 RPGRIP1L NCKAP1 MYO1E HJURP CCDC18 BRCC3 LYST DENND4C LUZP1 FAM83H KIF7 CEP170 ARFGEF3 RMDN3 PTPN3 ARRB2 TBC1D4 STARD9 KIF14 AKAP11 USP4 DNMBP RGL2 UTRN PHLDB2 KIF1C | 4.30e-07 | 1102 | 178 | 28 | int:YWHAH |
| Interaction | YWHAG interactions | KIF13B RC3H2 MTMR12 RPGRIP1L NCKAP1 HJURP CCDC18 BRCC3 OAZ1 LYST DENND4C LUZP1 FAM83H KIF7 CEP170 RMDN3 PTPN3 ARRB2 TBC1D4 STARD9 CEP250 CLTC KIF14 AKAP11 CDC5L DNMBP RGL2 UTRN PHLDB2 KIF1C | 5.08e-07 | 1248 | 178 | 30 | int:YWHAG |
| Interaction | NDC80 interactions | CCDC14 MAP9 RPGRIP1L CCDC18 ICE1 LUZP1 KIF7 CEP250 C19orf44 KIF14 CEP295 HERC2 CDC5L PHLDB2 | 7.58e-07 | 312 | 178 | 14 | int:NDC80 |
| Interaction | CEP135 interactions | CCDC14 RPGRIP1L CCDC18 LUZP1 ESF1 FAM83H KIF7 CEP170 CEP250 KIF14 CEP295 HERC2 PHLDB2 | 9.44e-07 | 272 | 178 | 13 | int:CEP135 |
| Interaction | LILRB1 interactions | 1.19e-06 | 10 | 178 | 4 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.19e-06 | 10 | 178 | 4 | int:LILRB2 | |
| Interaction | LIMA1 interactions | KIF13B NCKAP1 MYO1E BMP2K DENND4C LUZP1 ITPR3 ARRB2 CLTC KIF14 UBXN2A USP4 CDH1 UTRN PHLDB2 KIF1C | 1.40e-06 | 429 | 178 | 16 | int:LIMA1 |
| Interaction | VPS33B interactions | CCDC18 ARFGEF3 RMDN3 NBAS CLTC KIF14 AKAP11 CDC5L DNMBP PHLDB2 USP47 | 1.63e-06 | 199 | 178 | 11 | int:VPS33B |
| Interaction | YWHAZ interactions | KIF13B MTMR12 RPGRIP1L NCKAP1 MAP6 SPTA1 HJURP CCDC18 WDR76 LYST DENND4C LUZP1 FAM83H CEP170 FSIP2 RMDN3 PTPN3 TBC1D4 STARD9 CLTC KIF14 AKAP11 HERC2 CDC5L DNMBP CDH1 PHLDB2 USP47 KIF1C | 4.76e-06 | 1319 | 178 | 29 | int:YWHAZ |
| Interaction | YWHAE interactions | KIF13B RC3H2 MTMR12 RPGRIP1L NCKAP1 HJURP CCDC18 COL6A5 LYST DENND4C LUZP1 FAM83H CEP170 RMDN3 PTPN3 ARRB2 TBC1D4 STXBP1 CEP250 CLTC KIF14 AKAP11 CDC5L DNMBP CDH1 RGL2 PHLDB2 KIF1C | 5.48e-06 | 1256 | 178 | 28 | int:YWHAE |
| Interaction | KRT8 interactions | CCDC14 RPGRIP1L CCDC18 WDR76 FAM83H KIF7 ITPR3 TBC1D4 IGFBP3 KIF14 IRAK3 AKAP11 USP4 DNMBP CDH1 | 9.18e-06 | 441 | 178 | 15 | int:KRT8 |
| Interaction | CTNNB1 interactions | RTN4 MKRN2 OTUB1 NUP98 CASP8 CHD8 BRCC3 CHD4 ACTL6A CEP250 KIF14 USP4 HERC2 CTNND2 FSCN1 CROCC USP15 CDH1 CDH3 UTRN CDH8 CDH9 PHLDB2 ZNF639 | 9.60e-06 | 1009 | 178 | 24 | int:CTNNB1 |
| Interaction | SFN interactions | KIF13B MTMR12 CCDC18 LYST DENND4C LUZP1 FAM83H CEP170 PTPN3 PPP2R2B TBC1D4 CLTC KIF14 AKAP11 USP4 DNMBP CDH1 PHLDB2 USP47 | 1.25e-05 | 692 | 178 | 19 | int:SFN |
| Interaction | MAGEA9 interactions | CCDC14 RC3H2 SAMD9 ATAD5 HJURP ITPR3 STXBP1 ZFHX4 KIF14 HERC2 | 1.67e-05 | 208 | 178 | 10 | int:MAGEA9 |
| Interaction | NIN interactions | CCDC14 RPGRIP1L TUBGCP2 LUZP1 FAM83H KIF7 CEP170 ARFGEF3 CEP250 KIF14 CEP295 HERC2 PCID2 | 1.92e-05 | 359 | 178 | 13 | int:NIN |
| Interaction | CAMSAP2 interactions | 1.99e-05 | 169 | 178 | 9 | int:CAMSAP2 | |
| Interaction | SULT1C2 interactions | 2.06e-05 | 19 | 178 | 4 | int:SULT1C2 | |
| Interaction | DBN1 interactions | MYO1E BMP2K MKRN2 WDR76 LUZP1 PPP2R2B ARRB2 CLTC KIF14 HERC2 FSCN1 DNMBP CDH1 RAB5A | 2.13e-05 | 417 | 178 | 14 | int:DBN1 |
| Interaction | PRKAR2A interactions | 2.40e-05 | 217 | 178 | 10 | int:PRKAR2A | |
| Interaction | CLK1 interactions | AKAP5 MKRN2 CDH23 CUL9 PTPN22 ICE1 KIF14 DMBT1 CTNND2 PHLDB2 | 2.60e-05 | 219 | 178 | 10 | int:CLK1 |
| Interaction | CASK interactions | 2.81e-05 | 221 | 178 | 10 | int:CASK | |
| Interaction | BAG2 interactions | KIF13B RC3H2 ESS2 OTUB1 HJURP CHD4 TUBGCP2 WDR76 BRWD3 LUZP1 CEP170 PPP2R2B CLTC MFN2 KIF14 CDC5L KDM6A | 3.88e-05 | 622 | 178 | 17 | int:BAG2 |
| Interaction | MYH9 interactions | KIF13B SAMD9 MYO1E BMP2K MKRN2 CHD4 WDR76 LUZP1 ITPR3 ARRB2 CEP250 CLTC KIF14 MYOM2 CDC5L USP15 USP1 CDH1 USP47 | 4.05e-05 | 754 | 178 | 19 | int:MYH9 |
| Interaction | KRT19 interactions | CCDC14 CCDC18 CHD4 WDR76 LUZP1 FAM83H KIF7 IGFBP3 CEP295 DNMBP KIF1C | 4.37e-05 | 282 | 178 | 11 | int:KRT19 |
| Interaction | H2BC9 interactions | BTBD8 ENPP1 NUP98 CUL9 CHD4 ESF1 KIF7 FSIP2 TBC1D4 ZFHX4 AKAP11 FSCN1 CROCC CDH3 | 4.43e-05 | 446 | 178 | 14 | int:H2BC9 |
| Interaction | MED4 interactions | CCDC14 CCDC18 PTPN22 ACTL6A DENND4C LUZP1 KIF7 CEP170 ARRB2 KIF14 HERC2 USP15 UTRN RAB5A | 4.88e-05 | 450 | 178 | 14 | int:MED4 |
| Interaction | SPICE1 interactions | 5.20e-05 | 191 | 178 | 9 | int:SPICE1 | |
| Interaction | SYNPO interactions | 5.41e-05 | 192 | 178 | 9 | int:SYNPO | |
| Interaction | SULT4A1 interactions | 5.45e-05 | 24 | 178 | 4 | int:SULT4A1 | |
| Interaction | SULT1A3 interactions | 5.45e-05 | 24 | 178 | 4 | int:SULT1A3 | |
| Interaction | OFD1 interactions | CCDC14 RPGRIP1L MKRN2 CCDC18 ICE1 DENND4C LUZP1 CEP170 CLTC KIF14 CEP295 PHLDB2 | 6.31e-05 | 347 | 178 | 12 | int:OFD1 |
| Interaction | MIB1 interactions | CCDC14 MIS18BP1 ATAD5 MKRN2 CCDC18 PTPN22 MAP10 LUZP1 CEP250 KIF14 USP15 | 6.56e-05 | 295 | 178 | 11 | int:MIB1 |
| Interaction | HLA-E interactions | 7.11e-05 | 79 | 178 | 6 | int:HLA-E | |
| Interaction | CD8A interactions | 7.56e-05 | 26 | 178 | 4 | int:CD8A | |
| Interaction | ODF2 interactions | 8.26e-05 | 158 | 178 | 8 | int:ODF2 | |
| Interaction | VPS33A interactions | RC3H2 RPGRIP1L BRCC3 TUBGCP2 KIF7 CLTC CDC5L RAB5A PHLDB2 KIF1C | 8.76e-05 | 253 | 178 | 10 | int:VPS33A |
| Interaction | USP21 interactions | 9.42e-05 | 161 | 178 | 8 | int:USP21 | |
| Interaction | SIRT7 interactions | NCKAP1 UGGT1 NUP98 KRI1 CUL9 CHD8 CHD4 ESF1 ITPR3 PWP1 CEP170 CLTC KIF14 UTP20 HERC2 FSCN1 UTRN USP47 | 1.09e-04 | 744 | 178 | 18 | int:SIRT7 |
| Interaction | PLEC interactions | DNAH3 COL17A1 BMP2K SPTA1 CASP8 WDR76 LUZP1 PPP2R2B KIF14 USP4 HERC2 CDC5L CDH1 | 1.21e-04 | 430 | 178 | 13 | int:PLEC |
| Interaction | EZR interactions | HLA-A HLA-B NCKAP1 SPTA1 CCDC18 CASP8 LUZP1 KIF14 TBR1 CROCC USP1 CDH1 UTRN USP47 WDR44 | 1.22e-04 | 553 | 178 | 15 | int:EZR |
| Interaction | CTNND1 interactions | 1.28e-04 | 265 | 178 | 10 | int:CTNND1 | |
| Interaction | SIRT6 interactions | RNGTT MKRN2 NUP98 CHD8 CHD4 ACTL6A ESF1 ITPR3 PWP1 CEP170 CLTC HERC2 USP15 CDH1 EIF2AK3 ANAPC4 | 1.49e-04 | 628 | 178 | 16 | int:SIRT6 |
| Interaction | PRPF4 interactions | 1.54e-04 | 271 | 178 | 10 | int:PRPF4 | |
| Interaction | EPB41L3 interactions | 1.59e-04 | 272 | 178 | 10 | int:EPB41L3 | |
| Interaction | SYNE3 interactions | CCDC14 HLA-C UGGT1 CCDC18 NUP98 FAM83H KIF7 ITPR3 NBAS C19orf44 KIF14 CEP295 EIF2AK3 | 1.66e-04 | 444 | 178 | 13 | int:SYNE3 |
| Interaction | TRIM52 interactions | 1.82e-04 | 133 | 178 | 7 | int:TRIM52 | |
| Interaction | EGLN3 interactions | ESS2 HLA-A HLA-B HLA-C BMP2K UGGT1 OTUB1 HJURP CHD8 BRCC3 ICE1 TUBGCP2 FAM83H KIF7 CEP170 RMDN3 TBC1D4 MASTL MFN2 KIF14 AKAP11 CEP295 USP15 UTRN USP47 | 1.89e-04 | 1296 | 178 | 25 | int:EGLN3 |
| Interaction | CEP152 interactions | 1.96e-04 | 179 | 178 | 8 | int:CEP152 | |
| Interaction | CEP290 interactions | 1.96e-04 | 179 | 178 | 8 | int:CEP290 | |
| Interaction | UNC45A interactions | 2.00e-04 | 228 | 178 | 9 | int:UNC45A | |
| Interaction | SULT2B1 interactions | 2.03e-04 | 61 | 178 | 5 | int:SULT2B1 | |
| Interaction | FLNA interactions | RC3H2 NCKAP1 MYO1E BMP2K WDR76 LUZP1 ITPR3 PWP1 ARRB2 CLTC KIF14 USP4 FSCN1 USP15 CDH1 PHLDB2 | 2.12e-04 | 648 | 178 | 16 | int:FLNA |
| Interaction | MAPRE3 interactions | 2.13e-04 | 230 | 178 | 9 | int:MAPRE3 | |
| Interaction | PTEN interactions | MAN1A1 SPTA1 UGGT1 NUP98 CASP8 CHD4 ACTL6A LUZP1 ITPR3 CEP170 FSIP2 KIF14 USP4 FSCN1 USP1 CDH3 UTRN KDM6A ANAPC4 EPHB1 | 2.15e-04 | 929 | 178 | 20 | int:PTEN |
| Interaction | SULT1A4 interactions | 2.30e-04 | 14 | 178 | 3 | int:SULT1A4 | |
| Interaction | CCDC8 interactions | HLA-A HLA-C UGGT1 CUL9 CHD4 FAM83H KIF7 ITPR3 CEP170 BBS7 CEP250 CLTC UTP20 HERC2 UTRN PHLDB2 | 2.43e-04 | 656 | 178 | 16 | int:CCDC8 |
| Interaction | INPP5E interactions | 2.73e-04 | 65 | 178 | 5 | int:INPP5E | |
| Interaction | RALGDS interactions | 2.78e-04 | 36 | 178 | 4 | int:RALGDS | |
| Interaction | PRKAR2B interactions | 2.84e-04 | 143 | 178 | 7 | int:PRKAR2B | |
| Interaction | PHLDB2 interactions | 2.84e-04 | 143 | 178 | 7 | int:PHLDB2 | |
| Interaction | HOOK1 interactions | 2.92e-04 | 240 | 178 | 9 | int:HOOK1 | |
| Interaction | CDK5RAP2 interactions | 2.94e-04 | 190 | 178 | 8 | int:CDK5RAP2 | |
| Interaction | PCNT interactions | 3.01e-04 | 241 | 178 | 9 | int:PCNT | |
| Interaction | HDAC1 interactions | MKRN2 NUP98 DACH1 CHD8 BRCC3 CHD4 ACTL6A WDR76 DENND4C LUZP1 ARRB2 TBC1D4 ZFHX4 CEP250 KIF14 FSCN1 CROCC USP15 CDH1 UTRN USP47 ZNF639 | 3.19e-04 | 1108 | 178 | 22 | int:HDAC1 |
| Interaction | TNFRSF1B interactions | 3.22e-04 | 146 | 178 | 7 | int:TNFRSF1B | |
| Interaction | KIF7 interactions | 3.22e-04 | 146 | 178 | 7 | int:KIF7 | |
| Interaction | CNTRL interactions | 3.26e-04 | 193 | 178 | 8 | int:CNTRL | |
| Interaction | MACF1 interactions | 3.61e-04 | 247 | 178 | 9 | int:MACF1 | |
| Interaction | RHOA interactions | AKAP5 HLA-A HLA-B NCKAP1 MYO1E HLA-C RTN4 MKRN2 OTUB1 CASP8 TENM2 ITPR3 SULT1A1 CLTC KIF14 UTP20 ARHGAP20 CDH1 CDH3 UTRN EIF2AK3 PREX1 PHLDB2 | 3.77e-04 | 1199 | 178 | 23 | int:RHOA |
| Interaction | MYO7A interactions | 4.19e-04 | 40 | 178 | 4 | int:MYO7A | |
| Interaction | HLA-H interactions | 4.21e-04 | 17 | 178 | 3 | int:HLA-H | |
| Interaction | BRD2 interactions | CAAP1 ATAD5 CHD8 CHD4 ACTL6A WDR76 CEP170 SULT1A2 ARRB2 TBR1 CDC5L CROCC | 4.47e-04 | 429 | 178 | 12 | int:BRD2 |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 5.49e-10 | 46 | 118 | 8 | 622 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.64e-06 | 14 | 118 | 4 | 762 | |
| GeneFamily | WD repeat domain containing | 5.55e-05 | 262 | 118 | 9 | 362 | |
| GeneFamily | C1-set domain containing | 1.59e-04 | 42 | 118 | 4 | 591 | |
| GeneFamily | Dyneins, axonemal | 1.72e-04 | 17 | 118 | 3 | 536 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.91e-04 | 44 | 118 | 4 | 588 | |
| GeneFamily | CD molecules|Type I classical cadherins | 4.17e-04 | 5 | 118 | 2 | 1185 | |
| GeneFamily | Ubiquitin specific peptidases | 4.87e-04 | 56 | 118 | 4 | 366 | |
| GeneFamily | CD molecules|Type II classical cadherins | 3.14e-03 | 13 | 118 | 2 | 1186 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | GLS2 HLA-A HLA-B HLA-C HLA-G OAZ1 SULT1A2 SULT1A4 SULT1A1 SULT1A3 | 7.27e-08 | 147 | 179 | 10 | MM3753 |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.51e-07 | 19 | 179 | 5 | MM797 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ABHD17A SEMA4D RALGDS MIS18BP1 SAMD9 MAN1A1 HLA-A HLA-B HLA-C RGCC NUP98 KRI1 CASP8 PTPN22 OAZ1 ICE1 LYST LUZP1 PPP2R2B ARRB2 TBC1D4 AKAP11 USP15 USP1 UTRN PREX1 USP47 | 3.49e-06 | 1492 | 179 | 27 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 3.59e-06 | 16 | 179 | 4 | MM3766 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 6.70e-06 | 39 | 179 | 5 | MM3725 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 7.52e-06 | 19 | 179 | 4 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 9.36e-06 | 20 | 179 | 4 | MM3682 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN | 1.02e-05 | 200 | 179 | 9 | M9586 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.15e-05 | 21 | 179 | 4 | MM651 | |
| Coexpression | LE_EGR2_TARGETS_DN | 1.62e-05 | 117 | 179 | 7 | MM1139 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.01e-05 | 24 | 179 | 4 | MM1317 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 2.01e-05 | 24 | 179 | 4 | MM3773 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 2.10e-05 | 49 | 179 | 5 | MM1287 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 2.33e-05 | 222 | 179 | 9 | MM1132 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 2.38e-05 | 25 | 179 | 4 | MM672 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | MIS18BP1 BTBD8 NCKAP1 MAP6 RTN4 MKRN2 LYST ITPR3 CMTM8 PTPN3 TBC1D4 STXBP1 CLTC TMEM150C AKAP11 CDC5L USP1 UTRN RAB5A | 2.76e-05 | 946 | 179 | 19 | M39169 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | HLA-A HLA-B HLA-C RIPPLY3 HLA-G FAM83H SULT1A2 SULT1A4 SULT1A1 SULT1A3 ARHGAP20 CDH1 CDH8 | 3.47e-05 | 490 | 179 | 13 | MM1001 |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 3.61e-05 | 90 | 179 | 6 | MM750 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P7 | 3.84e-05 | 91 | 179 | 6 | M1736 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P7 | 4.35e-05 | 93 | 179 | 6 | MM1218 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 5.22e-05 | 59 | 179 | 5 | MM3704 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 5.73e-05 | 31 | 179 | 4 | MM3729 | |
| Coexpression | GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP | 6.59e-05 | 197 | 179 | 8 | M8170 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN | 6.59e-05 | 197 | 179 | 8 | M9580 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN | 6.82e-05 | 198 | 179 | 8 | M7229 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 7.07e-05 | 199 | 179 | 8 | M7259 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP | 7.32e-05 | 200 | 179 | 8 | M318 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 9.33e-05 | 35 | 179 | 4 | MM674 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 1.03e-04 | 68 | 179 | 5 | MM770 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | ABHD17A ZNF562 PTPN22 LYST BRWD3 ESF1 EDEM3 IRAK3 CDC5L USP1 USP47 | 1.07e-04 | 402 | 179 | 11 | M5275 |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 1.24e-04 | 161 | 179 | 7 | M11857 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | CCDC14 SEMA4D MTMR12 MIS18BP1 RPGRIP1L BMP2K ATAD5 HJURP CCDC18 WDR76 BBS7 KIF14 AKAP11 CEP295 HERC2 USP1 EIF2AK3 | 1.40e-04 | 892 | 179 | 17 | M18120 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.44e-04 | 39 | 179 | 4 | MM3758 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL | 1.46e-04 | 221 | 179 | 8 | M45789 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.55e-04 | 74 | 179 | 5 | MM3796 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 1.56e-04 | 167 | 179 | 7 | M361 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.65e-04 | 75 | 179 | 5 | MM1084 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 1.75e-04 | 41 | 179 | 4 | MM710 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | HLA-A HLA-B HLA-C RTN4 RGCC HJURP HLA-G CHD4 TUBGCP2 ITGA9 TG ADIPOQ TNFRSF19 FSCN1 CDH3 | 1.83e-04 | 741 | 179 | 15 | MM1037 |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP | 2.01e-04 | 174 | 179 | 7 | M6296 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 2.11e-04 | 43 | 179 | 4 | MM1204 | |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | SEMA4D STXBP1 IGFBP3 TULP4 HERC2 CDC5L FSCN1 CDH3 UTRN KDM6A EIF2AK3 RAB5A | 2.21e-04 | 512 | 179 | 12 | M4508 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 2.31e-04 | 44 | 179 | 4 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 2.51e-04 | 82 | 179 | 5 | MM3777 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MAP9 MIS18BP1 ATAD5 HJURP CCDC18 TUBGCP2 WDR76 HELQ GREB1L ARFGEF3 STXBP1 KIF14 CTNND2 ARHGAP20 | 2.54e-04 | 680 | 179 | 14 | MM456 |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 2.74e-04 | 46 | 179 | 4 | MM3712 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 2.80e-04 | 84 | 179 | 5 | MM1049 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 2.82e-04 | 184 | 179 | 7 | M9005 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 3.30e-04 | 87 | 179 | 5 | MM652 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 3.37e-04 | 250 | 179 | 8 | M11318 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 3.48e-04 | 88 | 179 | 5 | MM1087 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | SEMA4D MAP6 KIF26A DACH1 LYST TENM2 ARFGEF3 PPP2R2B STXBP1 RAB3A | 3.62e-04 | 389 | 179 | 10 | M39073 |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN | 3.76e-04 | 193 | 179 | 7 | M4284 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 3.79e-04 | 50 | 179 | 4 | MM3805 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 3.86e-04 | 90 | 179 | 5 | MM3756 | |
| Coexpression | GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN | 4.00e-04 | 195 | 179 | 7 | M5142 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RC3H2 MAN1A1 MYO1E DUSP3 HLA-G DACH1 ITGA9 LYST TENM2 DMXL1 ARFGEF3 EDEM3 TMEM150C MYOM2 KDM6A EPHB1 | 4.09e-04 | 888 | 179 | 16 | MM1018 |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP | 4.13e-04 | 196 | 179 | 7 | M6063 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 4.39e-04 | 198 | 179 | 7 | M9346 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN | 4.39e-04 | 198 | 179 | 7 | M325 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP | 4.39e-04 | 198 | 179 | 7 | M5584 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 4.41e-04 | 52 | 179 | 4 | MM3808 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN | 4.52e-04 | 199 | 179 | 7 | M3709 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 4.52e-04 | 199 | 179 | 7 | M7448 | |
| Coexpression | GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN | 4.52e-04 | 199 | 179 | 7 | M7690 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP | 4.52e-04 | 199 | 179 | 7 | M7766 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 4.58e-04 | 5 | 179 | 2 | M41007 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP | 4.66e-04 | 200 | 179 | 7 | M9489 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP | 4.66e-04 | 200 | 179 | 7 | M4584 | |
| Coexpression | GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN | 4.66e-04 | 200 | 179 | 7 | M9735 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN | 4.66e-04 | 200 | 179 | 7 | M3779 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 4.66e-04 | 200 | 179 | 7 | M7168 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN | 4.66e-04 | 200 | 179 | 7 | M8524 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_16H_BMDC_UP | 4.66e-04 | 200 | 179 | 7 | M3950 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 4.66e-04 | 200 | 179 | 7 | M7500 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP | 4.66e-04 | 200 | 179 | 7 | M6600 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP | 4.66e-04 | 200 | 179 | 7 | M6584 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN | 4.66e-04 | 200 | 179 | 7 | M4486 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TREG_DN | 4.66e-04 | 200 | 179 | 7 | M5744 | |
| Coexpression | GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN | 4.66e-04 | 200 | 179 | 7 | M4343 | |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 4.66e-04 | 200 | 179 | 7 | M6943 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | RPGRIP1L ESS2 HLA-A HLA-B HLA-C BMP2K DUSP3 HLA-G OAZ1 LYST SULT1A2 SULT1A4 SULT1A1 SULT1A3 | 4.69e-04 | 723 | 179 | 14 | MM3672 |
| Coexpression | JIANG_MELANOMA_TRM2_CD8 | 5.13e-04 | 146 | 179 | 6 | M48966 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_MONOCYTE_AGEING | 5.32e-04 | 147 | 179 | 6 | MM3707 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | RALGDS AKAP5 BMP2K ENPP1 HLA-G TIAM2 STARD9 CROCC PREX1 EPHB1 | 5.55e-04 | 411 | 179 | 10 | M1351 |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 5.86e-04 | 56 | 179 | 4 | MM3852 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RALGDS MAP6 RTN4 NOX4 LYST TENM2 ARFGEF3 FSIP2 PPP2R2B STXBP1 ZFHX4 TULP4 CACNA1I CTNND2 CAMTA1 RAB3A CDH8 EPHB1 | 5.96e-04 | 1106 | 179 | 18 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MIS18BP1 NOX4 BRCC3 ESF1 DMXL1 CEP170 KIF14 AKAP11 CDC5L CTNND2 USP1 CDH1 USP47 | 6.03e-04 | 656 | 179 | 13 | M18979 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | RALGDS AKAP5 BMP2K ENPP1 HLA-G TIAM2 STARD9 CROCC PREX1 EPHB1 | 6.09e-04 | 416 | 179 | 10 | MM1002 |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 6.26e-04 | 57 | 179 | 4 | MM3716 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN SPTA1 FREM1 ARFGEF3 ZFHX4 PKHD1 UNC13C MYOM2 DNAH9 UNC5D | 4.28e-09 | 184 | 180 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN SPTA1 FREM1 ARFGEF3 ZFHX4 PKHD1 UNC13C MYOM2 DNAH9 UNC5D | 4.28e-09 | 184 | 180 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN SPTA1 FREM1 ARFGEF3 ZFHX4 PKHD1 UNC13C MYOM2 DNAH9 UNC5D | 4.28e-09 | 184 | 180 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.98e-08 | 174 | 180 | 9 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 8.86e-08 | 191 | 180 | 9 | 2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 8.86e-08 | 191 | 180 | 9 | f802a4686ecf00e8302047bfe23356f24b266cf8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 9.26e-08 | 192 | 180 | 9 | 4d72b9264ed62e0c08cde4078061b348253f6989 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.01e-07 | 194 | 180 | 9 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-07 | 200 | 180 | 9 | 0f8e2fed93cc103b20a825d8d3e83787c5c015cc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.65e-07 | 174 | 180 | 8 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 6.43e-07 | 177 | 180 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.97e-07 | 185 | 180 | 8 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 189 | 180 | 8 | 4225bbff4037eecc93a12abad3a38dd04b1e22be | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.05e-06 | 189 | 180 | 8 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.10e-06 | 190 | 180 | 8 | cb4cf8ae2156c20b7978ae2e55aa605b4e90f455 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 191 | 180 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|metastatic_Brain / Location, Cell class and cell subclass | 1.14e-06 | 191 | 180 | 8 | b98367fdb56ccb335d61035e69cd43c61a7fa816 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 191 | 180 | 8 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 191 | 180 | 8 | 1aac4f839c2f83dac924fdb5d8d0c76687dacd2a | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 192 | 180 | 8 | 9da21ce330f3b5661f159cf18d1c3e5ccc11d6dd | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 192 | 180 | 8 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.19e-06 | 192 | 180 | 8 | 5841378789d8267f94071df060debc9171700784 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-06 | 193 | 180 | 8 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.23e-06 | 193 | 180 | 8 | 48809047d3194aff225fc43c3d5152c20434fe62 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-06 | 193 | 180 | 8 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 194 | 180 | 8 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 194 | 180 | 8 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.33e-06 | 195 | 180 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.33e-06 | 195 | 180 | 8 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 195 | 180 | 8 | ec3b7a7257edd806a2364f7dda0ee0996c11f896 | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class | 1.49e-06 | 198 | 180 | 8 | 1d12be256af028c88e31fb535068bae16b7bd48e | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.49e-06 | 198 | 180 | 8 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-06 | 199 | 180 | 8 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 1.55e-06 | 199 | 180 | 8 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 1.55e-06 | 199 | 180 | 8 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.55e-06 | 199 | 180 | 8 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-06 | 199 | 180 | 8 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.55e-06 | 199 | 180 | 8 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-06 | 199 | 180 | 8 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 1.55e-06 | 199 | 180 | 8 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.61e-06 | 200 | 180 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-06 | 200 | 180 | 8 | 56d738ff019682af7f1f8cbe7b262a75dc8596d5 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 1.61e-06 | 200 | 180 | 8 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-06 | 200 | 180 | 8 | 7eed3d932018d6a87ce37d013883b371db55caeb | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 1.61e-06 | 200 | 180 | 8 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.61e-06 | 200 | 180 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.61e-06 | 200 | 180 | 8 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.24e-06 | 161 | 180 | 7 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 162 | 180 | 7 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-06 | 172 | 180 | 7 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.79e-06 | 173 | 180 | 7 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.79e-06 | 173 | 180 | 7 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.33e-06 | 175 | 180 | 7 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.33e-06 | 175 | 180 | 7 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-06 | 175 | 180 | 7 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-06 | 175 | 180 | 7 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 7.89e-06 | 177 | 180 | 7 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 8.18e-06 | 178 | 180 | 7 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 9.46e-06 | 182 | 180 | 7 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 9.46e-06 | 182 | 180 | 7 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 182 | 180 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 186 | 180 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 186 | 180 | 7 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 186 | 180 | 7 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 186 | 180 | 7 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.13e-05 | 187 | 180 | 7 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 187 | 180 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 189 | 180 | 7 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 189 | 180 | 7 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 1.21e-05 | 189 | 180 | 7 | e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23 | |
| ToppCell | (1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.21e-05 | 189 | 180 | 7 | 62eda4bcfd21d5025ac676d524994ede22721c1d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 1.25e-05 | 190 | 180 | 7 | 4225bfa10a6fb909a3ba8ac26f3541c390b46737 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | ee63dc04e91ad49aa7820c98e97261176ecebaa6 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.25e-05 | 190 | 180 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-05 | 190 | 180 | 7 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | control-CD8+_Tem|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-05 | 190 | 180 | 7 | 1200074e358f164d36bf22800a17ce0fca319560 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 1.25e-05 | 190 | 180 | 7 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | b0c9dae8189d407c94964c6bfe3ef92035245357 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-05 | 190 | 180 | 7 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 190 | 180 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | 0e50808bfc3d0820524c8470ae3e8250819d65b2 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-05 | 190 | 180 | 7 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.25e-05 | 190 | 180 | 7 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 191 | 180 | 7 | 767269dbd799e08c4ebba13e8c968fb148acf182 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.29e-05 | 191 | 180 | 7 | b2d0ea24970da09209da9d9dda76e30fbfe22917 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 192 | 180 | 7 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 192 | 180 | 7 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 192 | 180 | 7 | 5dd206adb8b84c374ee931f7df2a8b8cf040efab | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-05 | 192 | 180 | 7 | 0f8c63de26128694f4522f9f6d029e4628c890bc | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 192 | 180 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 192 | 180 | 7 | 1a2dd398141069ef6ad2f6bb4bae0bac1c6b98e8 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-05 | 192 | 180 | 7 | 01d01c9293f2439dc4c34c648273319c9beee5c7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-05 | 192 | 180 | 7 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.38e-05 | 193 | 180 | 7 | 053adc7ed9f997b503e12239a684bb9f5896e10c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.38e-05 | 193 | 180 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8_low_T|normal_Lymph_Node / Location, Cell class and cell subclass | 1.38e-05 | 193 | 180 | 7 | e20ad6b62ad3aa386aa10b7a5d057d24a64ad386 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.38e-05 | 193 | 180 | 7 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.38e-05 | 193 | 180 | 7 | 3184a5f454e3ac5a81f6bacf9bd8f07d9d448fba | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.38e-05 | 193 | 180 | 7 | 123d4d13c8944c32bf4a5d7fdc65e3b65aa568ef | |
| Computational | Genes in the cancer module 293. | 6.17e-06 | 12 | 117 | 4 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 1.23e-05 | 14 | 117 | 4 | MODULE_143 | |
| Computational | Neighborhood of PTPRC | 9.24e-05 | 68 | 117 | 6 | GNF2_PTPRC | |
| Drug | A-44 | 1.06e-07 | 16 | 176 | 5 | CID000120353 | |
| Drug | dopamine-4-O-sulfate | 1.19e-07 | 7 | 176 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 1.19e-07 | 7 | 176 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 1.19e-07 | 7 | 176 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 1.19e-07 | 7 | 176 | 4 | CID011953812 | |
| Drug | dopamine 3-O-sulfate | 2.36e-07 | 8 | 176 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 2.36e-07 | 8 | 176 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 2.36e-07 | 8 | 176 | 4 | CID000010784 | |
| Drug | EM-139 | 2.34e-06 | 13 | 176 | 4 | CID000131427 | |
| Drug | 3,3'-T2 | 3.18e-06 | 30 | 176 | 5 | CID000065559 | |
| Drug | naphthalenemethanol | 3.25e-06 | 14 | 176 | 4 | CID000020908 | |
| Drug | deoxoestrone | 3.25e-06 | 14 | 176 | 4 | CID000005888 | |
| Drug | arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A | 3.42e-06 | 198 | 176 | 10 | 594_DN | |
| Drug | arylsulfate | 4.41e-06 | 15 | 176 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 4.41e-06 | 15 | 176 | 4 | CID000002895 | |
| Drug | benzilic acid | 7.59e-06 | 17 | 176 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 1.22e-05 | 19 | 176 | 4 | CID000115063 | |
| Drug | pedunculagin | 1.22e-05 | 19 | 176 | 4 | CID000442688 | |
| Drug | PLP-Glu | 1.52e-05 | 20 | 176 | 4 | CID000444293 | |
| Drug | Phosphoadenosine Phosphosulfate | 1.55e-05 | 7 | 176 | 3 | ctd:D010724 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.64e-05 | 188 | 176 | 9 | 4845_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.85e-05 | 191 | 176 | 9 | 6020_DN | |
| Drug | N-hydroxy-2-aminofluorene | 1.86e-05 | 21 | 176 | 4 | CID000005895 | |
| Drug | MeA alpha C | 2.26e-05 | 22 | 176 | 4 | CID000062244 | |
| Drug | AABSSN | 2.26e-05 | 22 | 176 | 4 | CID005464134 | |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.28e-05 | 196 | 176 | 9 | 3516_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; PC3; HG-U133A | MAN1A1 NCKAP1 RIPPLY3 NUP98 ACTL6A DMXL1 STXBP1 DMBT1 EIF2AK3 | 2.28e-05 | 196 | 176 | 9 | 1909_DN |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 6758_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 4837_DN | |
| Drug | N-hydroxy-4-aminobiphenyl | 2.47e-05 | 8 | 176 | 3 | ctd:C014593 | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.57e-05 | 199 | 176 | 9 | 1467_DN | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; PC3; HT_HG-U133A | 2.67e-05 | 200 | 176 | 9 | 4579_UP | |
| Drug | taselin | 2.72e-05 | 23 | 176 | 4 | CID000023846 | |
| Drug | PD184352 | 2.77e-05 | 46 | 176 | 5 | CID006918454 | |
| Drug | AalphaC | 3.25e-05 | 24 | 176 | 4 | CID000062805 | |
| Drug | sulfamethazine | 3.41e-05 | 48 | 176 | 5 | CID000005327 | |
| Drug | procyanidin A2 | 3.69e-05 | 9 | 176 | 3 | CID000124025 | |
| Drug | AzMC | 3.84e-05 | 25 | 176 | 4 | CID000064986 | |
| Drug | minoxidil sulphate | 3.84e-05 | 25 | 176 | 4 | CID000004202 | |
| Drug | 2-pentanone | 3.84e-05 | 25 | 176 | 4 | CID000007895 | |
| Drug | reverse T3 | 4.22e-05 | 82 | 176 | 6 | CID000022069 | |
| Drug | alpha-methyldopamine | 4.52e-05 | 26 | 176 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 4.52e-05 | 26 | 176 | 4 | CID000115245 | |
| Drug | 1m2q | 4.52e-05 | 26 | 176 | 4 | CID005326637 | |
| Drug | Hydroxytryptophol | 5.94e-05 | 2 | 176 | 2 | ctd:D006917 | |
| Drug | 5-hydroxymethylfurfural | 5.94e-05 | 2 | 176 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 5.94e-05 | 2 | 176 | 2 | ctd:C012365 | |
| Drug | Glu-P-2 | 7.05e-05 | 29 | 176 | 4 | CID000049970 | |
| Drug | NSC36919 | 8.58e-05 | 58 | 176 | 5 | CID000235496 | |
| Drug | tert-butyl acetate | 8.58e-05 | 58 | 176 | 5 | CID000010908 | |
| Drug | A2'p5'A2'p5'A | 9.22e-05 | 31 | 176 | 4 | CID000122642 | |
| Drug | barium hydroxide | 9.22e-05 | 31 | 176 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 9.22e-05 | 31 | 176 | 4 | CID000083939 | |
| Drug | etorphine | 9.31e-05 | 59 | 176 | 5 | CID000026721 | |
| Drug | DCNP | 1.19e-04 | 33 | 176 | 4 | CID000012066 | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 1.20e-04 | 190 | 176 | 8 | 5926_DN | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.24e-04 | 191 | 176 | 8 | 4580_UP | |
| Drug | 3-OHBaP | 1.28e-04 | 63 | 176 | 5 | CID000025890 | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; PC3; HT_HG-U133A | 1.29e-04 | 192 | 176 | 8 | 6713_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 192 | 176 | 8 | 6025_DN | |
| Drug | AC1L3XN4 | 1.34e-04 | 34 | 176 | 4 | CID000123968 | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 3366_DN | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 4953_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 3725_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 3169_DN | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 2820_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 7327_DN | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 5523_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 7357_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 5298_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 6263_DN | |
| Drug | Oxyquinoline | 1.49e-04 | 250 | 176 | 9 | ctd:D015125 | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 5244_DN | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 5090_DN | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 7543_DN | |
| Drug | 5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 1.53e-04 | 197 | 176 | 8 | 834_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 7293_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 1237_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 3413_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 7349_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6267_UP | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7532_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 4346_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 5698_DN | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7436_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 5749_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.70e-04 | 200 | 176 | 8 | 6034_DN | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.70e-04 | 200 | 176 | 8 | 4588_UP | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.70e-04 | 200 | 176 | 8 | 6992_DN | |
| Drug | 8-azaadenine | 1.77e-04 | 3 | 176 | 2 | ctd:C006654 | |
| Drug | Cefadroxil | 1.77e-04 | 3 | 176 | 2 | ctd:D002434 | |
| Drug | 3,3'-diiodothyronine | 1.77e-04 | 3 | 176 | 2 | ctd:C030629 | |
| Drug | 5-hydroxy-3-methylindole | 1.77e-04 | 3 | 176 | 2 | CID000192734 | |
| Drug | 5-hydroxyindole | 1.77e-04 | 3 | 176 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.77e-04 | 3 | 176 | 2 | ctd:D008914 | |
| Drug | mefenamic acid | 1.87e-04 | 37 | 176 | 4 | CID000004044 | |
| Drug | TP-6 | 1.93e-04 | 15 | 176 | 3 | CID011987821 | |
| Drug | AC1L1FCN | 1.93e-04 | 15 | 176 | 3 | CID000003178 | |
| Drug | phenylhydroxylamine | 2.07e-04 | 38 | 176 | 4 | CID000007518 | |
| Drug | Pyrethroids | 2.25e-04 | 71 | 176 | 5 | CID000005053 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 3.85e-08 | 7 | 172 | 4 | DOID:0081267 (implicated_via_orthology) | |
| Disease | beta-2 microglobulin measurement | 3.10e-05 | 11 | 172 | 3 | EFO_0005197 | |
| Disease | – | 3.38e-05 | 2 | 172 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 3.38e-05 | 2 | 172 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 3.38e-05 | 2 | 172 | 2 | cv:CN077964 | |
| Disease | Undifferentiated carcinoma of ovary | 3.38e-05 | 2 | 172 | 2 | C0346167 | |
| Disease | Disorder of eye | 3.66e-05 | 212 | 172 | 8 | C0015397 | |
| Disease | Ciliopathies | 4.66e-05 | 110 | 172 | 6 | C4277690 | |
| Disease | susceptibility to childhood ear infection measurement | 6.80e-05 | 171 | 172 | 7 | EFO_0007904 | |
| Disease | urate measurement, bone density | COL6A5 TENM2 DNAH14 FREM1 TIAM2 TG FSIP2 KIF14 DMBT1 CTNND2 DNAH9 UTRN EPHB1 | 7.47e-05 | 619 | 172 | 13 | EFO_0003923, EFO_0004531 |
| Disease | Glioma | 1.59e-04 | 87 | 172 | 5 | C0017638 | |
| Disease | comparative body size at age 10, self-reported | HLA-A HLA-B PLCD4 ADAMTS10 EDEM3 STXBP1 TSBP1 PKHD1 CAMTA1 ANAPC4 | 1.90e-04 | 420 | 172 | 10 | EFO_0009819 |
| Disease | TYPE 1 DIABETES MELLITUS | 2.01e-04 | 4 | 172 | 2 | 222100 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 2.01e-04 | 4 | 172 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | Diabetes mellitus type 1 | 2.01e-04 | 4 | 172 | 2 | cv:C0011854 | |
| Disease | red blood cell density measurement | GLS2 HLA-B BMP2K SPTA1 CHD4 TG PTPN3 TBC1D4 SULT1A1 PKHD1 UBXN2A CAMTA1 CROCC USP1 PREX1 | 2.11e-04 | 880 | 172 | 15 | EFO_0007978 |
| Disease | Headache, HbA1c measurement | 2.40e-04 | 21 | 172 | 3 | EFO_0004541, HP_0002315 | |
| Disease | complement C4 measurement | 2.43e-04 | 52 | 172 | 4 | EFO_0004984 | |
| Disease | hemoglobin A1 measurement | RC3H2 ENPP1 SPTA1 CASP8 WDR76 KL TULP4 USP4 CDH1 ANAPC4 KIF1C | 2.53e-04 | 520 | 172 | 11 | EFO_0007629 |
| Disease | breast cancer (is_implicated_in) | 2.57e-04 | 150 | 172 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | platelet-to-lymphocyte ratio | 2.96e-04 | 363 | 172 | 9 | EFO_0008446 | |
| Disease | polyp of colon | 3.23e-04 | 56 | 172 | 4 | MONDO_0021400 | |
| Disease | allergic asthma (is_implicated_in) | 3.34e-04 | 5 | 172 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | Congenital absence of kidneys syndrome | 3.34e-04 | 5 | 172 | 2 | C1609433 | |
| Disease | drug-induced liver injury | 3.60e-04 | 24 | 172 | 3 | EFO_0004228 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 3.60e-04 | 24 | 172 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | lymphocyte count | ZAN HLA-A HLA-B HLA-C SPTA1 RTN4 HLA-G CDH23 CASP8 PTPN22 LYST ARRB2 UMODL1 TSBP1 C19orf44 UBXN2A USP4 DMBT1 CDC5L PREX1 | 3.61e-04 | 1464 | 172 | 20 | EFO_0004587 |
| Disease | smoking status measurement | CAAP1 SAMD9 KIF26A HLA-G DACH1 TENM2 TULP4 PKHD1 TTL CEP295 CTNND2 CAMTA1 USP15 CDH1 UTRN CDH8 EPHB1 | 4.65e-04 | 1160 | 172 | 17 | EFO_0006527 |
| Disease | age at diagnosis, type 1 diabetes mellitus | 4.78e-04 | 62 | 172 | 4 | EFO_0004918, MONDO_0005147 | |
| Disease | cerebrospinal fluid biomarker measurement, monocyte chemotactic protein 1 measurement | 4.99e-04 | 6 | 172 | 2 | EFO_0006794, EFO_0010596 | |
| Disease | Meniere's disease (is_implicated_in) | 4.99e-04 | 6 | 172 | 2 | DOID:9849 (is_implicated_in) | |
| Disease | Myocardial Ischemia | 6.02e-04 | 176 | 172 | 6 | C0151744 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 6.36e-04 | 29 | 172 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 6.36e-04 | 29 | 172 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 6.36e-04 | 29 | 172 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 6.36e-04 | 29 | 172 | 3 | C0014518 | |
| Disease | chronic lymphocytic leukemia | 6.79e-04 | 119 | 172 | 5 | EFO_0000095 | |
| Disease | Stevens-Johnson Syndrome | 7.04e-04 | 30 | 172 | 3 | C0038325 | |
| Disease | Malignant Glioma | 7.58e-04 | 70 | 172 | 4 | C0555198 | |
| Disease | mixed gliomas | 7.58e-04 | 70 | 172 | 4 | C0259783 | |
| Disease | basal cell carcinoma | 8.72e-04 | 189 | 172 | 6 | EFO_0004193 | |
| Disease | Colorectal Carcinoma | RALGDS RELCH DNAH3 RTN4 CASP8 KL IGFBP3 PKHD1 CTNND2 CDH1 KDM6A ANAPC4 | 8.92e-04 | 702 | 172 | 12 | C0009402 |
| Disease | Unilateral agenesis of kidney | 9.24e-04 | 8 | 172 | 2 | C0266294 | |
| Disease | non-melanoma skin carcinoma | 9.67e-04 | 265 | 172 | 7 | EFO_0009260 | |
| Disease | behavioural disinhibition measurement | 9.82e-04 | 75 | 172 | 4 | EFO_0006946 | |
| Disease | susceptibility to mumps measurement | 9.82e-04 | 75 | 172 | 4 | EFO_0008404 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.03e-03 | 195 | 172 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.18e-03 | 9 | 172 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | reticulocyte count | ATRN SEMA4D GLS2 HLA-A HLA-C BMP2K SPTA1 HLA-G GREB1L TSBP1 UBXN2A USP4 CDH1 PCID2 KIF1C | 1.24e-03 | 1045 | 172 | 15 | EFO_0007986 |
| Disease | Graves disease | 1.31e-03 | 81 | 172 | 4 | EFO_0004237 | |
| Disease | coronary artery calcification | 1.36e-03 | 450 | 172 | 9 | EFO_0004723 | |
| Disease | non-receptor tyrosine-protein kinase TYK2 measurement | 1.47e-03 | 10 | 172 | 2 | EFO_0008251 | |
| Disease | ankylosing spondylitis (is_marker_for) | 1.47e-03 | 10 | 172 | 2 | DOID:7147 (is_marker_for) | |
| Disease | Graves' disease (is_implicated_in) | 1.52e-03 | 39 | 172 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.56e-03 | 85 | 172 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | Macrocephaly | 1.79e-03 | 11 | 172 | 2 | C0221355 | |
| Disease | glucose measurement | 1.82e-03 | 380 | 172 | 8 | EFO_0004468 | |
| Disease | lymphocyte percentage of leukocytes | HLA-A HLA-B SPTA1 HLA-G CDH23 CASP8 ARRB2 UMODL1 UBXN2A CROCC PREX1 | 1.88e-03 | 665 | 172 | 11 | EFO_0007993 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-03 | 152 | 172 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | spleen volume | 2.02e-03 | 43 | 172 | 3 | EFO_0600047 | |
| Disease | Amelogenesis Imperfecta | 2.15e-03 | 12 | 172 | 2 | C0002452 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.15e-03 | 12 | 172 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 2.15e-03 | 12 | 172 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 2.15e-03 | 12 | 172 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 2.15e-03 | 12 | 172 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | granulins measurement | 2.15e-03 | 12 | 172 | 2 | EFO_0008141 | |
| Disease | X-12707 measurement | 2.15e-03 | 12 | 172 | 2 | EFO_0800720 | |
| Disease | lung carcinoma | 2.17e-03 | 482 | 172 | 9 | EFO_0001071 | |
| Disease | body fat percentage | 2.36e-03 | 488 | 172 | 9 | EFO_0007800 | |
| Disease | cirrhosis of liver | 2.53e-03 | 13 | 172 | 2 | EFO_0001422 | |
| Disease | Myasthenia gravis | 2.53e-03 | 13 | 172 | 2 | EFO_0004991 | |
| Disease | Vitiligo | 2.93e-03 | 101 | 172 | 4 | EFO_0004208 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.94e-03 | 14 | 172 | 2 | EFO_0800173 | |
| Disease | smoking cessation | 3.07e-03 | 325 | 172 | 7 | EFO_0004319 | |
| Disease | neutrophil percentage of leukocytes | 3.20e-03 | 610 | 172 | 10 | EFO_0007990 | |
| Disease | lung adenocarcinoma, family history of lung cancer | 3.30e-03 | 51 | 172 | 3 | EFO_0000571, EFO_0006953 | |
| Disease | sitting height ratio | 3.30e-03 | 51 | 172 | 3 | EFO_0007118 | |
| Disease | cleft lip (is_implicated_in) | 3.37e-03 | 15 | 172 | 2 | DOID:9296 (is_implicated_in) | |
| Disease | body weights and measures, body height | 3.37e-03 | 15 | 172 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | Graves' disease (is_marker_for) | 3.37e-03 | 15 | 172 | 2 | DOID:12361 (is_marker_for) | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 3.37e-03 | 15 | 172 | 2 | EFO_0801746 | |
| Disease | Chromosome Aberrations | 3.84e-03 | 16 | 172 | 2 | C0008625 | |
| Disease | response to thioamide, Drug-induced agranulocytosis | 3.84e-03 | 16 | 172 | 2 | EFO_0007633, HP_0012235 | |
| Disease | Autosome Abnormalities | 3.84e-03 | 16 | 172 | 2 | C0004403 | |
| Disease | amyloid-beta measurement, Alzheimer's disease biomarker measurement | 3.84e-03 | 16 | 172 | 2 | EFO_0005194, EFO_0006514 | |
| Disease | platelet crit | DNAH3 HLA-A HLA-B MYO1E KIF26A DACH1 CASP8 TULP4 MFN2 UBXN2A USP15 CDH3 PREX1 | 3.97e-03 | 952 | 172 | 13 | EFO_0007985 |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 3.98e-03 | 110 | 172 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | pathological myopia | 4.11e-03 | 111 | 172 | 4 | EFO_0004207 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.34e-03 | 17 | 172 | 2 | C2936862 | |
| Disease | Moyamoya Disease | 4.34e-03 | 17 | 172 | 2 | C0026654 | |
| Disease | cervical carcinoma | 4.37e-03 | 182 | 172 | 5 | EFO_0001061 | |
| Disease | heel bone mineral density, urate measurement | 4.37e-03 | 182 | 172 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | Autistic Disorder | 4.40e-03 | 261 | 172 | 6 | C0004352 | |
| Disease | C-X-C motif chemokine 16 measurement | 4.86e-03 | 18 | 172 | 2 | EFO_0010911 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 4.86e-03 | 18 | 172 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Meckel syndrome type 1 | 4.86e-03 | 18 | 172 | 2 | C3714506 | |
| Disease | disease free survival | 4.86e-03 | 18 | 172 | 2 | EFO_0000409 | |
| Disease | cognitive function measurement, self reported educational attainment | 4.96e-03 | 355 | 172 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | prostate cancer (is_implicated_in) | 4.96e-03 | 117 | 172 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | lip morphology measurement | 5.11e-03 | 189 | 172 | 5 | EFO_0007845 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFRNASSQEYRDFLE | 806 | Q5DID0 | |
| ISSDDSKEDYSLNND | 136 | Q96QE3 | |
| SKEDYSLNNDFVESS | 141 | Q96QE3 | |
| DYASTSEDEFGSNRN | 1236 | Q5SW79 | |
| ATYAAENSDSFRSEL | 1236 | Q9UMD9 | |
| DLDENFLNSSYQTVF | 346 | Q5W0A0 | |
| NNSFLRDHSYATEAD | 11 | Q00005 | |
| SCDSESNDNFLLATY | 431 | Q8IWZ6 | |
| SQGYDSSERDFSLID | 2551 | Q9HCK8 | |
| DTSEENYQALDADFR | 226 | Q99459 | |
| NTELGSYRDSAENEE | 1371 | Q9Y6Y1 | |
| ESSVLTSFYNAEDES | 121 | Q9UJX5 | |
| FDDTSYTSNDDVLED | 356 | Q9NZJ5 | |
| SQTVDRADFRSYEEN | 1111 | Q86TB3 | |
| RNGLYADNDNDSTFT | 221 | Q15848 | |
| NAEYNRNSSVVSESD | 721 | Q9Y3Q7 | |
| DETDTSYFEARNTAQ | 856 | Q96GX5 | |
| DFQASVLQVSDSTYD | 261 | O96019 | |
| ERQQDSSLSEDYQDV | 1351 | Q6RI45 | |
| TVLYNDDSDNDNFVS | 1756 | Q6RI45 | |
| TERADFQYSQRELDT | 71 | Q96GS6 | |
| FYRSSNASDKDSDLQ | 281 | Q9UKA4 | |
| SEYDTDRNSYQDEDT | 366 | Q6XZF7 | |
| DSDVLSINADAYDSD | 251 | Q9H8G2 | |
| DSSYSANRSVADKEA | 591 | Q9NSY1 | |
| DFETLYNDCTNASSR | 271 | Q9UI36 | |
| ELDEAVQFSNASYEA | 1306 | Q9H251 | |
| NEDSGSETAYLENRS | 121 | Q49A88 | |
| SSNYTESFSTLDEND | 2001 | Q9Y485 | |
| QNSTRNYDESFFEDQ | 1161 | Q9UQB3 | |
| TNLIEFDTNYATDDD | 371 | P32121 | |
| FRSQDEFLSSLESYE | 26 | Q9H324 | |
| DSSATYNLDEENRFR | 391 | Q8NCD3 | |
| DDVEASSSYSNEQQL | 156 | Q9H000 | |
| RNGELQSDYTEDATD | 1036 | Q9HBD1 | |
| SSELEDSTDYAFLNK | 96 | Q6ZP01 | |
| YESLQNTADSALDFS | 396 | Q6ZP01 | |
| DSRYGQKESSDQNFD | 6 | P20336 | |
| RAVDFQEAQSYADDN | 141 | P20339 | |
| ITSDEDSSYINANFI | 76 | Q9Y2R2 | |
| DDSSDFLEFVNYVRS | 816 | P26045 | |
| TIKDYDSNLNASRDD | 811 | Q14573 | |
| YVDDTQFVRFDSDSA | 51 | P17693 | |
| RSSSDYAQREDFEAA | 286 | Q06416 | |
| SLDFARYSDDGNRET | 186 | Q9P260 | |
| NYKLTSITFSDENDD | 271 | Q9P260 | |
| SDFGLSRYLQDDTSD | 761 | P54762 | |
| EQEINSAETYFESAR | 131 | Q9H3L0 | |
| ESIRNLASDFYSDFS | 1536 | Q15058 | |
| EAFQNTSDSDRYACS | 1451 | P52948 | |
| KYLDSDASFTENSDT | 561 | Q9P2G4 | |
| TAQRATTTYDFDCDN | 516 | Q6P0N0 | |
| EEVASAVSSSYRNEF | 291 | Q96JE9 | |
| SARQRSSEYSDDFDS | 36 | Q49MG5 | |
| DLTNTSRFYDRNDIE | 66 | O60942 | |
| TYSDEFGNLDFERSQ | 751 | Q9UJA3 | |
| LSFYVFDDSDTQENI | 861 | Q68CZ1 | |
| SSDELQDNFREFYDS | 601 | Q9C0I1 | |
| NEDVDSFASDSTQDY | 4816 | O95714 | |
| IDYQFTFSLSQEDDR | 1161 | O75882 | |
| AEADQDFSDENRTYQ | 571 | O43861 | |
| NTTSEYTELDDSNFD | 511 | Q9BZQ6 | |
| AQYQASSFQESLREE | 1036 | O15550 | |
| DSIFYDSSQVESDVN | 2296 | Q5CZC0 | |
| FYDLSDSDSNLSGED | 71 | Q9H501 | |
| YVDDTQFVRFDSDAA | 51 | P10321 | |
| SNTDNNLAVYDLSRD | 51 | Q5H943 | |
| RASDVDASDDYIFFN | 546 | Q5H8C1 | |
| QATIDFYDDESTESA | 106 | P57055 | |
| SDFDETLNTLNYASR | 331 | Q2M1P5 | |
| EQQRLYADSDSGDDS | 666 | O43896 | |
| TFYNRTASSSDSEED | 86 | Q8N9T8 | |
| ISSINDEFDAYTSQA | 1076 | Q9ULI4 | |
| DRSFSYTGDSQAQEL | 361 | Q9BSJ2 | |
| QDSYTLSETQAEAAA | 576 | Q9UI32 | |
| KEEYSFQSEEDQRNT | 211 | Q9BYG7 | |
| DSFSTEDFSNCLYQD | 701 | P22413 | |
| NTLESTQASLYFAED | 441 | Q9Y616 | |
| SANLFYSDDRLNVTE | 91 | P54368 | |
| ERLSRYNSTSQAFAE | 21 | Q8N3Z3 | |
| YFCEDADFNLRTNSS | 1711 | Q9C091 | |
| YVDDTQFVRFDSDAA | 51 | P01889 | |
| AASREYFNSSTNLTD | 1176 | A2RRP1 | |
| NELTFNAEEYSDISE | 821 | Q9Y2A7 | |
| QESATFLEDTYRNAE | 51 | O95140 | |
| SVNYSEDFVELNAAR | 131 | Q9NPH5 | |
| ASSAFEESRNTLTYA | 326 | Q2TAC6 | |
| DDAYDANVSFNVSRE | 666 | Q13797 | |
| DSSNLKDDYSTAQRV | 196 | Q5JVF3 | |
| ADLLASFNDQSTSDY | 156 | Q96FW1 | |
| FLSRYTSEDNASFQE | 151 | Q96DF8 | |
| EEESFNAYFSNEHSR | 281 | Q5TZA2 | |
| FGEYTDSSDNDSVQL | 371 | Q9Y2F5 | |
| ANRSSYDVFQLEFND | 406 | Q16658 | |
| SNYDSSRNIEEYFAS | 426 | Q8TD57 | |
| LTYNLEADSSENNDF | 1406 | Q5T9S5 | |
| VNTVSSAYSEDFENS | 461 | Q9H6X5 | |
| ISDRDDDFISNDNYD | 171 | Q5XKL5 | |
| YSESNFSVDDQDLSR | 591 | Q5TH69 | |
| QDLSRTEFDSCDQYS | 601 | Q5TH69 | |
| ANRSYSDEDQSSSNI | 871 | Q9P0X4 | |
| FALDNSYDVTEESFN | 1761 | A8TX70 | |
| LDSSIFSQFDYQDAD | 371 | Q9BV73 | |
| YESLLSDSNSNQSRD | 1156 | Q5VZ89 | |
| ASAYSYSDDEEETNR | 1381 | Q5VZ89 | |
| NDNGFEDRTSEQYET | 376 | P24588 | |
| NDYEEFSKERSSSLE | 176 | Q14790 | |
| DSSRTYSLDEFCEEQ | 346 | Q0VDD8 | |
| YVDDTQFVRFDSDAA | 51 | P04439 | |
| YFVEDNASDTVESSS | 3041 | Q99698 | |
| AYTQRSSTDFSELEQ | 951 | Q86V48 | |
| SEIFSDENNYSLSRE | 516 | Q12967 | |
| ESYDDVQQSFFLAET | 596 | P33908 | |
| NDTQEFNLSAYFERA | 91 | P51452 | |
| TGDVASDSYNNVFRD | 121 | Q9UEF7 | |
| SDSYNNVFRDTEALR | 126 | Q9UEF7 | |
| RSASQALQAYIDDFD | 46 | Q8IYD9 | |
| SYDESENLDQETFFF | 2491 | Q8IWT3 | |
| ERDEDNLNYTDSFDN | 531 | A6NGE4 | |
| SSSDCLYLQSTDFEN | 496 | Q9NYC9 | |
| SLESTTSDSDQNFDY | 761 | P55286 | |
| YDSFTENSFIAQVDD | 111 | Q8TDG4 | |
| ATANALYSSNLRDDT | 1026 | Q6ZRV2 | |
| DVESDFDDASINSYS | 316 | Q14839 | |
| SSVYSSSDEANVFDQ | 2236 | Q9C0D2 | |
| ADNDTIDYSNFLTAA | 2186 | Q9UGM3 | |
| SSLESLTADCNQDYD | 751 | Q9ULB4 | |
| TSSASDQDQDYDYLN | 796 | P22223 | |
| ATDADDDVNTYNAAI | 286 | P12830 | |
| SSLNSSESDKDQDYD | 846 | P12830 | |
| DTQNFSSESKRETEY | 196 | P17936 | |
| DNNYDETLSTLRYAN | 316 | Q9P2E2 | |
| DSSSEVSSEVNFNYE | 576 | Q9NQT8 | |
| NDSSYDSLENELNED | 581 | Q9P2F6 | |
| AAQDSETDYVTTDNL | 521 | Q9NQC3 | |
| AEEDIYDTSRQATAF | 2211 | O75691 | |
| NTAIYEDFSFQEDSL | 1896 | P46939 | |
| QIFSEEDNYSQSREL | 386 | O15211 | |
| YTTANAESDNERDSD | 176 | Q96TC7 | |
| NRLDFAASAYDTATD | 491 | Q16650 | |
| DQEYAFSLFQAADTS | 171 | Q9BRC7 | |
| SAFKESQQQSEDREY | 1161 | Q5K651 | |
| SSSEFEDLNAYASQR | 81 | A0A1B0GUV7 | |
| SEDQSFQRLSYELAF | 81 | Q8NE18 | |
| IDQYDVQRDDSSDGS | 91 | O14793 | |
| NNNGEYEESSRDASR | 1351 | Q8TCU6 | |
| NFTYSTDNDVTELID | 1616 | Q9NT68 | |
| ESNASVIFDYSDDGR | 1991 | Q9NT68 | |
| ADDFTSRYLNASDFT | 821 | P08F94 | |
| EYQENFLSFSESLSE | 226 | B9EJG8 | |
| IDSEARAANYTSSLN | 371 | Q92854 | |
| KDNDLSDTDSNYSLD | 1096 | Q9P2P6 | |
| YKDQAFDTLSLDSSD | 996 | Q86SQ0 | |
| ESQVYSLDSADSFQS | 141 | P61764 | |
| TTFTVAQNERFDADY | 266 | P0DMN0 | |
| TTFTVAQNERFDADY | 266 | P0DMM9 | |
| ELNDDTRSDSKFAYT | 41 | P46736 | |
| RTSIDAYDNFDNISL | 1481 | Q00610 | |
| ENFSTSSSSFAYDRE | 21 | Q8IZV2 | |
| STDDGFVYNLDARSD | 361 | Q13610 | |
| LNYREDSNILSFDSD | 1011 | A0JNW5 | |
| SARDRTDYVNSAFTE | 1076 | Q9NRJ4 | |
| TDYVNSAFTEDEALS | 1081 | Q9NRJ4 | |
| DHRSNSYQDSVTFDD | 31 | Q6V9R5 | |
| AGYDQNKTDFDETSS | 2746 | Q86UP3 | |
| YFDDSNVSLASEDQI | 896 | Q13107 | |
| YDIETENNSSESLQD | 151 | Q9UID6 | |
| DSDEDLESDLNRNSY | 451 | Q8NB66 | |
| STQEGFDYETNSLFD | 671 | Q8NB66 | |
| SDYFDSRSDGLNTDV | 406 | Q8IVF5 | |
| TTFTVAQNERFDADY | 266 | P50225 | |
| TTFTVAQNERFDADY | 266 | P50226 | |
| DSESADSLYRNSFSF | 76 | Q9H4X1 | |
| DDFRSYSDGASQQFL | 76 | P68543 | |
| YASNQEFESVRLNET | 1086 | Q96K76 | |
| RTKEYVSNDAAQSDD | 391 | Q5JSH3 | |
| YFDDSSVSTASEDQI | 906 | Q9Y4E8 | |
| SYDDRFQSADETGQD | 421 | P02549 | |
| SESQLDEADFNYSRQ | 936 | Q6UXZ4 | |
| SFERSNSLASEKDYS | 591 | O60343 | |
| AQSTDNDVNYEDFTF | 16 | Q16378 | |
| SENFTAATDLSRYNN | 366 | Q9NS68 | |
| EEVYRNERSSFSSFD | 396 | Q9H967 | |
| YKNESDTFSDSRSSD | 836 | Q9NS56 | |
| DNSVSESLDEFDYSV | 51 | Q14139 | |
| YSTQSDTSYDNRERS | 61 | Q5SRN2 | |
| DDYASFSRALENATR | 2571 | P01266 | |
| SNSRTDEREFFLASY | 121 | Q8NG68 | |
| TAERDYLDLTASNNF | 701 | Q9NYU2 | |
| DSQENEEKASEYRAS | 41 | O94782 | |
| SSRDNYVLTQCDFED | 31 | Q9Y493 | |
| AYDAQDTDELSFNAN | 1061 | Q12965 | |
| INRADFDDTATYSAV | 216 | P54296 |